Component
Copper(II) ion
Independent ion record; interpretation is limited by each linked claim and its study context.
51 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
CuCl2 exposure promoted NRF2 nuclear translocation in the tested cancer cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/copper-research/40944334.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6df1716e8998546d22a1d96116e1bc35b1f7e24c94868ec5e441ada6a2be3e89", "start_char": 0, "end_char": 1634, "text_sha256": "6df1716e8998546d22a1d96116e1bc35b1f7e24c94868ec5e441ada6a2be3e89"}
- experimental_model
- Copper and iron exposure with transcription-factor knockdown
- exposure
- CuCl2 or FeCl2 exposure; NFE2L2 or ATOX1 knockdown
- limitations
- One cancer-cell model. Expression changes do not prove increased glutathione synthesis, tumor progression, or a clinical nutrient interaction.
- nutrient_topic
- Copper research collection; topical membership is not evidence of a direct dietary effect. · Copper
- organism
- Human MDA-MB-231 breast cancer cells
- plain_language
- A stress-response regulator moved to the cell’s DNA-containing compartment.
- primary_references
- [copper-p40944334] Copper induces cystine/glutamate antiporter SLC7A11 through the activation of Nrf2 and Atox1 pathways. (2025). https://pubmed.ncbi.nlm.nih.gov/40944334/ DOI: 10.1080/10715762.2025.2560847
- tissue_or_cell_type
- Cellular amino-acid transport machinery
Copper: transport, cuproenzymes, deficiency, excess and nutrient interactions (2026-09-17) · lines 1287–1298
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Copper and iron exposure with transcription-factor knockdown · source_derived_draft · unverified_draft
### copper-cu-nrf2 CuCl2 exposure promoted NRF2 nuclear translocation in the tested cancer cells. Condition category: normal nutrient_topic: Copper research collection; topical membership is not evidence of a direct dietary effect. plain_language: A stress-response regulator moved to the cell’s DNA-containing compartment. organism: Human MDA-MB-231 breast cancer cells tissue_or_cell_type: Cellular amino-acid transport machinery experimental_model: Copper and iron exposure with transcription-factor knockdown limitations: One cancer-cell model. Expression changes do not prove increased glutathione synthesis, tumor progression, or a clinical nutrient interaction. exposure: CuCl2 or FeCl2 exposure; NFE2L2 or ATOX1 knockdown evidence_span: {"source_cache": "artifacts/copper-research/40944334.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6df1716e8998546d22a1d96116e1bc35b1f7e24c94868ec5e441ada6a2be3e89", "start_char": 0, "end_char": 1634, "text_sha256": "6df1716e8998546d22a1d96116e1bc35b1f7e24c94868ec5e441ada6a2be3e89"} [copper-p40944334] Copper induces cystine/glutamate antiporter SLC7A11 through the activation of Nrf2 and Atox1 pathways. (2025). https://pubmed.ncbi.nlm.nih.gov/40944334/ DOI: 10.1080/10715762.2025.2560847
Complete structured claim and evidenceCuCl2 treatment induced SLC7A11 expression in human MDA-MB-231 cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/copper-research/40944334.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6df1716e8998546d22a1d96116e1bc35b1f7e24c94868ec5e441ada6a2be3e89", "start_char": 0, "end_char": 1634, "text_sha256": "6df1716e8998546d22a1d96116e1bc35b1f7e24c94868ec5e441ada6a2be3e89"}
- experimental_model
- Copper and iron exposure with transcription-factor knockdown
- exposure
- CuCl2 or FeCl2 exposure; NFE2L2 or ATOX1 knockdown
- limitations
- One cancer-cell model. Expression changes do not prove increased glutathione synthesis, tumor progression, or a clinical nutrient interaction.
- nutrient_topic
- Copper research collection; topical membership is not evidence of a direct dietary effect. · Copper
- organism
- Human MDA-MB-231 breast cancer cells
- plain_language
- Copper exposure changed part of the cystine-entry system in these cells.
- primary_references
- [copper-p40944334] Copper induces cystine/glutamate antiporter SLC7A11 through the activation of Nrf2 and Atox1 pathways. (2025). https://pubmed.ncbi.nlm.nih.gov/40944334/ DOI: 10.1080/10715762.2025.2560847
- tissue_or_cell_type
- Cellular amino-acid transport machinery
Copper: transport, cuproenzymes, deficiency, excess and nutrient interactions (2026-09-17) · lines 1274–1285
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Copper and iron exposure with transcription-factor knockdown · source_derived_draft · unverified_draft
### copper-cu-slc7a11 CuCl2 treatment induced SLC7A11 expression in human MDA-MB-231 cells. Condition category: normal nutrient_topic: Copper research collection; topical membership is not evidence of a direct dietary effect. plain_language: Copper exposure changed part of the cystine-entry system in these cells. organism: Human MDA-MB-231 breast cancer cells tissue_or_cell_type: Cellular amino-acid transport machinery experimental_model: Copper and iron exposure with transcription-factor knockdown limitations: One cancer-cell model. Expression changes do not prove increased glutathione synthesis, tumor progression, or a clinical nutrient interaction. exposure: CuCl2 or FeCl2 exposure; NFE2L2 or ATOX1 knockdown evidence_span: {"source_cache": "artifacts/copper-research/40944334.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6df1716e8998546d22a1d96116e1bc35b1f7e24c94868ec5e441ada6a2be3e89", "start_char": 0, "end_char": 1634, "text_sha256": "6df1716e8998546d22a1d96116e1bc35b1f7e24c94868ec5e441ada6a2be3e89"} [copper-p40944334] Copper induces cystine/glutamate antiporter SLC7A11 through the activation of Nrf2 and Atox1 pathways. (2025). https://pubmed.ncbi.nlm.nih.gov/40944334/ DOI: 10.1080/10715762.2025.2560847
Complete structured claim and evidenceCopper inhibited rat-liver CACT carnitine exchange in proteoliposomes, with a native-protein IC50 of 1.6 micromolar.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Native rat-liver carrier; recombinant cysteine mutants supported involvement of C136 and C155.
- limitations
- Free copper in an assay is not dietary copper exposure; no clinical deficiency or toxicity threshold follows.
- nutrient_topic
- L-Carnitine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnitine
- plain_language
- Metal exposure can interfere with the carrier in a controlled assay.
- primary_references
- Effect of Copper on the Mitochondrial Carnitine/Acylcarnitine Carrier Via Interaction with Cys136 and Cys155. Possible Implications in Pathophysiology. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32070004/ · DOI 10.3390/molecules25040820
L-Carnitine: synthesis, acyl-group transport, fuel selection and nutrient interactions (2026-09-19) · lines 138–144
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Native rat-liver carrier; recombinant cysteine mutants supported involvement of C136 and C155. · source_derived_draft · unverified_draft
## l-carnitine-copper-carrier Metal exposure can interfere with the carrier in a controlled assay. Copper inhibited rat-liver CACT carnitine exchange in proteoliposomes, with a native-protein IC50 of 1.6 micromolar. Model: Native rat-liver carrier; recombinant cysteine mutants supported involvement of C136 and C155. Limitations: Free copper in an assay is not dietary copper exposure; no clinical deficiency or toxicity threshold follows. Evidence access: Primary abstract Effect of Copper on the Mitochondrial Carnitine/Acylcarnitine Carrier Via Interaction with Cys136 and Cys155. Possible Implications in Pathophysiology. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32070004/ · DOI 10.3390/molecules25040820
Complete structured claim and evidenceDietary copper availability altered tendon lysyl-oxidase activation in the chick experiments.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- experimental_model
- Chicks receiving diets differing in copper; tendon enzyme assays.
- limitations
- Copper manipulation in chicks, not evidence of dietary lysine deficiency or a human copper/lysine dose recommendation.
- organism
- Chicken
- plain_language
- Insufficient copper can limit a lysine-processing enzyme even when its substrate is present.
- primary_references
- [lox-copper-1999] Activation of chick tendon lysyl oxidase in response to dietary copper (1999). https://pubmed.ncbi.nlm.nih.gov/10573541/
- tissue_or_cell_type
- Tendon
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 497–505
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Chicks receiving diets differing in copper; tendon enzyme assays. · source_derived_draft · unverified_draft
### copper-insufficiency-lox Dietary copper availability altered tendon lysyl-oxidase activation in the chick experiments. Plain language: Insufficient copper can limit a lysine-processing enzyme even when its substrate is present. Condition category: nutrient_deficiency organism: Chicken tissue_or_cell_type: Tendon experimental_model: Chicks receiving diets differing in copper; tendon enzyme assays. limitations: Copper manipulation in chicks, not evidence of dietary lysine deficiency or a human copper/lysine dose recommendation. [lox-copper-1999] Activation of chick tendon lysyl oxidase in response to dietary copper (1999). https://pubmed.ncbi.nlm.nih.gov/10573541/
Complete structured claim and evidencePituitary peptide-amidating activity inhibited by divalent-metal chelators was restored above control by copper addition; the assayed reaction also required molecular oxygen.
Experimental context and source evidence
- cross_nutrient
- Vitamin C chemistry in collagen, modified-lysine/carnitine metabolism or copper-dependent peptide/catecholamine processing.
- experimental_model
- Rat pituitary and bovine intermediate-pituitary secretory-granule preparations
- exposure
- Synthetic D-Tyr-Val-Gly amidation with varied ascorbate, oxygen and divalent-metal chelators/copper.
- limitations
- Study included rat and bovine preparations; this cofactor observation is scoped to those preparations rather than a human nutritional copper trial.
- nutrient_topic
- Vitamin C research collection; topical membership is not evidence of a direct dietary effect. · Vitamin C
- organism
- Rattus norvegicus; Bos taurus
- plain_language
- Vitamin C and copper participate together, and removing available metal stops this peptide-processing assay.
- primary_references
- [pam1983] Identification in pituitary tissue of a peptide alpha-amidation activity that acts on glycine-extended peptides and requires molecular oxygen, copper, and ascorbic acid. (1983). https://pubmed.ncbi.nlm.nih.gov/6576381/ DOI: 10.1073/pnas.80.16.5144
- tissue_or_cell_type
- Pituitary secretory granules
Vitamin C: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 872–883
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Rat pituitary and bovine intermediate-pituitary secretory-granule preparations · source_derived_draft · unverified_draft
### vc-enzyme-amidation-copper-recovery Pituitary peptide-amidating activity inhibited by divalent-metal chelators was restored above control by copper addition; the assayed reaction also required molecular oxygen. Condition category: normal nutrient_topic: Vitamin C research collection; topical membership is not evidence of a direct dietary effect. plain_language: Vitamin C and copper participate together, and removing available metal stops this peptide-processing assay. organism: Rattus norvegicus; Bos taurus tissue_or_cell_type: Pituitary secretory granules experimental_model: Rat pituitary and bovine intermediate-pituitary secretory-granule preparations limitations: Study included rat and bovine preparations; this cofactor observation is scoped to those preparations rather than a human nutritional copper trial. cross_nutrient: Vitamin C chemistry in collagen, modified-lysine/carnitine metabolism or copper-dependent peptide/catecholamine processing. exposure: Synthetic D-Tyr-Val-Gly amidation with varied ascorbate, oxygen and divalent-metal chelators/copper. [pam1983] Identification in pituitary tissue of a peptide alpha-amidation activity that acts on glycine-extended peptides and requires molecular oxygen, copper, and ascorbic acid. (1983). https://pubmed.ncbi.nlm.nih.gov/6576381/ DOI: 10.1073/pnas.80.16.5144
Complete structured claim and evidence
What acts on it
Expressed mouse Steap2 reduced Cu(II) to Cu(I) and increased cellular copper uptake in the tested human cell system.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/copper-research/16609065.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d0f42a3f30c22ba4235d82f21ba165c78b6c519a6218f487411fb2247ecc0d9f", "start_char": 0, "end_char": 827, "text_sha256": "d0f42a3f30c22ba4235d82f21ba165c78b6c519a6218f487411fb2247ecc0d9f"}
- experimental_model
- Mouse Steap expression constructs and metal-reduction assays
- exposure
- Transient expression of Steap2, Steap3 or Steap4
- limitations
- Protein species verified in primary Methods (PMC1785011). Overexpression does not establish the dominant intestinal reductase in humans; relative activity can reflect localization and abundance.
- nutrient_topic
- Copper research collection; topical membership is not evidence of a direct dietary effect. · Copper
- organism
- Mouse proteins expressed in human HEK293T cells
- plain_language
- This enzyme prepares copper in a chemical form compatible with uptake.
- primary_references
- [copper-p16609065] The Steap proteins are metalloreductases. (2006). https://pubmed.ncbi.nlm.nih.gov/16609065/ DOI: 10.1182/blood-2006-02-003681
- tissue_or_cell_type
- Cell surface and endosomal compartments
Copper: transport, cuproenzymes, deficiency, excess and nutrient interactions (2026-09-17) · lines 273–284
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Mouse Steap expression constructs and metal-reduction assays · source_derived_draft · unverified_draft
### copper-steap2-reduces-copper Expressed mouse Steap2 reduced Cu(II) to Cu(I) and increased cellular copper uptake in the tested human cell system. Condition category: normal nutrient_topic: Copper research collection; topical membership is not evidence of a direct dietary effect. plain_language: This enzyme prepares copper in a chemical form compatible with uptake. organism: Mouse proteins expressed in human HEK293T cells tissue_or_cell_type: Cell surface and endosomal compartments experimental_model: Mouse Steap expression constructs and metal-reduction assays limitations: Protein species verified in primary Methods (PMC1785011). Overexpression does not establish the dominant intestinal reductase in humans; relative activity can reflect localization and abundance. exposure: Transient expression of Steap2, Steap3 or Steap4 evidence_span: {"source_cache": "artifacts/copper-research/16609065.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d0f42a3f30c22ba4235d82f21ba165c78b6c519a6218f487411fb2247ecc0d9f", "start_char": 0, "end_char": 827, "text_sha256": "d0f42a3f30c22ba4235d82f21ba165c78b6c519a6218f487411fb2247ecc0d9f"} [copper-p16609065] The Steap proteins are metalloreductases. (2006). https://pubmed.ncbi.nlm.nih.gov/16609065/ DOI: 10.1182/blood-2006-02-003681
Complete structured claim and evidenceExpressed mouse Steap3 reduced Cu(II) to Cu(I) and increased cellular copper uptake in the tested human cell system.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/copper-research/16609065.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d0f42a3f30c22ba4235d82f21ba165c78b6c519a6218f487411fb2247ecc0d9f", "start_char": 0, "end_char": 827, "text_sha256": "d0f42a3f30c22ba4235d82f21ba165c78b6c519a6218f487411fb2247ecc0d9f"}
- experimental_model
- Mouse Steap expression constructs and metal-reduction assays
- exposure
- Transient expression of Steap2, Steap3 or Steap4
- limitations
- Protein species verified in primary Methods (PMC1785011). Overexpression does not establish the dominant intestinal reductase in humans; relative activity can reflect localization and abundance.
- nutrient_topic
- Copper research collection; topical membership is not evidence of a direct dietary effect. · Copper
- organism
- Mouse proteins expressed in human HEK293T cells
- plain_language
- This enzyme prepares copper in a chemical form compatible with uptake.
- primary_references
- [copper-p16609065] The Steap proteins are metalloreductases. (2006). https://pubmed.ncbi.nlm.nih.gov/16609065/ DOI: 10.1182/blood-2006-02-003681
- tissue_or_cell_type
- Cell surface and endosomal compartments
Copper: transport, cuproenzymes, deficiency, excess and nutrient interactions (2026-09-17) · lines 286–297
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Mouse Steap expression constructs and metal-reduction assays · source_derived_draft · unverified_draft
### copper-steap3-reduces-copper Expressed mouse Steap3 reduced Cu(II) to Cu(I) and increased cellular copper uptake in the tested human cell system. Condition category: normal nutrient_topic: Copper research collection; topical membership is not evidence of a direct dietary effect. plain_language: This enzyme prepares copper in a chemical form compatible with uptake. organism: Mouse proteins expressed in human HEK293T cells tissue_or_cell_type: Cell surface and endosomal compartments experimental_model: Mouse Steap expression constructs and metal-reduction assays limitations: Protein species verified in primary Methods (PMC1785011). Overexpression does not establish the dominant intestinal reductase in humans; relative activity can reflect localization and abundance. exposure: Transient expression of Steap2, Steap3 or Steap4 evidence_span: {"source_cache": "artifacts/copper-research/16609065.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d0f42a3f30c22ba4235d82f21ba165c78b6c519a6218f487411fb2247ecc0d9f", "start_char": 0, "end_char": 827, "text_sha256": "d0f42a3f30c22ba4235d82f21ba165c78b6c519a6218f487411fb2247ecc0d9f"} [copper-p16609065] The Steap proteins are metalloreductases. (2006). https://pubmed.ncbi.nlm.nih.gov/16609065/ DOI: 10.1182/blood-2006-02-003681
Complete structured claim and evidenceExpressed mouse Steap4 reduced Cu(II) to Cu(I) and increased cellular copper uptake in the tested human cell system.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/copper-research/16609065.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d0f42a3f30c22ba4235d82f21ba165c78b6c519a6218f487411fb2247ecc0d9f", "start_char": 0, "end_char": 827, "text_sha256": "d0f42a3f30c22ba4235d82f21ba165c78b6c519a6218f487411fb2247ecc0d9f"}
- experimental_model
- Mouse Steap expression constructs and metal-reduction assays
- exposure
- Transient expression of Steap2, Steap3 or Steap4
- limitations
- Protein species verified in primary Methods (PMC1785011). Overexpression does not establish the dominant intestinal reductase in humans; relative activity can reflect localization and abundance.
- nutrient_topic
- Copper research collection; topical membership is not evidence of a direct dietary effect. · Copper
- organism
- Mouse proteins expressed in human HEK293T cells
- plain_language
- This enzyme prepares copper in a chemical form compatible with uptake.
- primary_references
- [copper-p16609065] The Steap proteins are metalloreductases. (2006). https://pubmed.ncbi.nlm.nih.gov/16609065/ DOI: 10.1182/blood-2006-02-003681
- tissue_or_cell_type
- Cell surface and endosomal compartments
Copper: transport, cuproenzymes, deficiency, excess and nutrient interactions (2026-09-17) · lines 299–310
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Mouse Steap expression constructs and metal-reduction assays · source_derived_draft · unverified_draft
### copper-steap4-reduces-copper Expressed mouse Steap4 reduced Cu(II) to Cu(I) and increased cellular copper uptake in the tested human cell system. Condition category: normal nutrient_topic: Copper research collection; topical membership is not evidence of a direct dietary effect. plain_language: This enzyme prepares copper in a chemical form compatible with uptake. organism: Mouse proteins expressed in human HEK293T cells tissue_or_cell_type: Cell surface and endosomal compartments experimental_model: Mouse Steap expression constructs and metal-reduction assays limitations: Protein species verified in primary Methods (PMC1785011). Overexpression does not establish the dominant intestinal reductase in humans; relative activity can reflect localization and abundance. exposure: Transient expression of Steap2, Steap3 or Steap4 evidence_span: {"source_cache": "artifacts/copper-research/16609065.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d0f42a3f30c22ba4235d82f21ba165c78b6c519a6218f487411fb2247ecc0d9f", "start_char": 0, "end_char": 827, "text_sha256": "d0f42a3f30c22ba4235d82f21ba165c78b6c519a6218f487411fb2247ecc0d9f"} [copper-p16609065] The Steap proteins are metalloreductases. (2006). https://pubmed.ncbi.nlm.nih.gov/16609065/ DOI: 10.1182/blood-2006-02-003681
Complete structured claim and evidenceSpectroscopy assigned Cu(II) coordination by luteolin to the 5-hydroxyl/4-carbonyl region.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cell-free Cu(II) spectroscopy.
- limitations
- Metal, pH and preparation matter; no human copper-balance measurement.
- nutrient_topic
- Luteolin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Luteolin / 3′,4′,5,7-tetrahydroxyflavone
- plain_language
- Copper need not bind at the same site assigned for iron.
- primary_references
- The effect of Luteolin on DNA damage mediated by a copper catalyzed Fenton reaction. · 2022 · https://pubmed.ncbi.nlm.nih.gov/34717250/ · DOI 10.1016/j.jinorgbio.2021.111635
Luteolin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 316–322
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Cell-free Cu(II) spectroscopy. · source_derived_draft · unverified_draft
## luteolin-copper-binding Copper need not bind at the same site assigned for iron. Spectroscopy assigned Cu(II) coordination by luteolin to the 5-hydroxyl/4-carbonyl region. Model: Cell-free Cu(II) spectroscopy. Limitations: Metal, pH and preparation matter; no human copper-balance measurement. Evidence access: Primary abstract The effect of Luteolin on DNA damage mediated by a copper catalyzed Fenton reaction. · 2022 · https://pubmed.ncbi.nlm.nih.gov/34717250/ · DOI 10.1016/j.jinorgbio.2021.111635
Complete structured claim and evidenceDHLA favored copper reduction when copper was in excess and chelation when DHLA was in excess.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/ala-research/9680174.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ac15770e92102947345520296b7795e8ff2dca2c345ac76c14b929fbd19739f1", "start_char": 0, "end_char": 2034, "text_sha256": "ac15770e92102947345520296b7795e8ff2dca2c345ac76c14b929fbd19739f1"}
- experimental_model
- Cell-free human LDL oxidation and electron-spin-resonance assays
- exposure
- Copper 5 micromolar; DHLA 0–20 micromolar; oxygen and pH varied
- limitations
- Metal binding, reduction and radical production depend on ratio, oxygen and pH; not evidence for human metal-detoxification efficacy.
- nutrient_topic
- Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. · Lipoic acid
- organism
- Human LDL; cell-free chemistry
- plain_language
- Whether copper was bound or chemically reduced depended on the relative amounts.
- primary_references
- [ala-p9680174] Thiol chelation of Cu2+ by dihydrolipoic acid prevents human low density lipoprotein peroxidation. (1998). https://pubmed.ncbi.nlm.nih.gov/9680174/ DOI: 10.1016/s0891-5849(98)00048-3
- tissue_or_cell_type
- LDL and copper/DHLA solutions
Alpha-lipoic acid: cofactor assembly, redox signaling and nutrient interactions (2026-09-17) · lines 1053–1064
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell-free human LDL oxidation and electron-spin-resonance assays · source_derived_draft · unverified_draft
### ala-dhla-copper-ratio DHLA favored copper reduction when copper was in excess and chelation when DHLA was in excess. Condition category: normal nutrient_topic: Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: Whether copper was bound or chemically reduced depended on the relative amounts. organism: Human LDL; cell-free chemistry tissue_or_cell_type: LDL and copper/DHLA solutions experimental_model: Cell-free human LDL oxidation and electron-spin-resonance assays limitations: Metal binding, reduction and radical production depend on ratio, oxygen and pH; not evidence for human metal-detoxification efficacy. exposure: Copper 5 micromolar; DHLA 0–20 micromolar; oxygen and pH varied evidence_span: {"source_cache": "artifacts/ala-research/9680174.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ac15770e92102947345520296b7795e8ff2dca2c345ac76c14b929fbd19739f1", "start_char": 0, "end_char": 2034, "text_sha256": "ac15770e92102947345520296b7795e8ff2dca2c345ac76c14b929fbd19739f1"} [ala-p9680174] Thiol chelation of Cu2+ by dihydrolipoic acid prevents human low density lipoprotein peroxidation. (1998). https://pubmed.ncbi.nlm.nih.gov/9680174/ DOI: 10.1016/s0891-5849(98)00048-3
Complete structured claim and evidenceDialysis and centrifugation showed copper association with the tested fulvic mixture.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Single oral radiocopper dose to 10-12-day-old rats; 0.93 mg Cu/L with 10 mg fulvic/L; chemical fractionation.
- limitations
- Binding is not evidence of improved systemic delivery.
- nutrient_topic
- Fulvic acid collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Fulvic acid (heterogeneous humic fraction)
- plain_language
- Copper can bind components of the mixture.
- primary_references
- Intestinal absorption of copper from drinking water containing fulvic acids and an infant formula mixture studied in a suckling rat model. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10406087/ · DOI 10.1023/a:1009233802104
Fulvic acid: mixture identity, mineral chemistry, signaling and cross-nutrient mechanisms (2026-09-19) · lines 76–82
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Single oral radiocopper dose to 10-12-day-old rats; 0.93 mg Cu/L with 10 mg fulvic/L; chemical fractionation. · source_derived_draft · unverified_draft
## fulvic-acid-copper-binding Copper can bind components of the mixture. Dialysis and centrifugation showed copper association with the tested fulvic mixture. Model: Single oral radiocopper dose to 10-12-day-old rats; 0.93 mg Cu/L with 10 mg fulvic/L; chemical fractionation. Limitations: Binding is not evidence of improved systemic delivery. Evidence access: Primary abstract Intestinal absorption of copper from drinking water containing fulvic acids and an infant formula mixture studied in a suckling rat model. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10406087/ · DOI 10.1023/a:1009233802104
Complete structured claim and evidenceMetformin can occur as an anion in aqueous medium at moderate pH and forms much stronger complexes with Cu(II) ions than the comparator propanediimidamide, suggesting that biguanides may induce oxidation of Cu(I) ions extracted from proteins.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/metformin-research/24433134.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a6dda36e30a49ba48e8200b6de36f39a8ab80a1bcbda819c03d3442bb8705963", "start_char": 0, "end_char": 1430, "text_sha256": "a6dda36e30a49ba48e8200b6de36f39a8ab80a1bcbda819c03d3442bb8705963"}
- experimental_model
- Computational and binding comparison of metformin and propanediimidamide with copper
- exposure
- Copper(I) and copper(II) binding energies, pKa and hydrophilicity
- limitations
- A chemistry study proposing a pro-oxidant role. It is explicitly a hypothesis about mitochondrial activity, not a cellular measurement.
- nutrient_topic
- Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. · Metformin
- organism
- Chemical and computational
- plain_language
- The drug grabs copper tightly enough that it could pull it off proteins and oxidise it.
- primary_references
- [metformin-p24433134] Biomolecular mode of action of metformin in relation to its copper binding properties. (2014). https://pubmed.ncbi.nlm.nih.gov/24433134/ DOI: 10.1021/bi401444n
- tissue_or_cell_type
- Molecular interaction
Metformin: transport, molecular targets, gut mechanisms and nutrient interactions (2026-09-19) · lines 1373–1384
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Computational and binding comparison of metformin and propanediimidamide with copper · source_derived_draft · unverified_draft
### metformin-copper-binding-chemistry Metformin can occur as an anion in aqueous medium at moderate pH and forms much stronger complexes with Cu(II) ions than the comparator propanediimidamide, suggesting that biguanides may induce oxidation of Cu(I) ions extracted from proteins. Condition category: normal nutrient_topic: Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. plain_language: The drug grabs copper tightly enough that it could pull it off proteins and oxidise it. organism: Chemical and computational tissue_or_cell_type: Molecular interaction experimental_model: Computational and binding comparison of metformin and propanediimidamide with copper limitations: A chemistry study proposing a pro-oxidant role. It is explicitly a hypothesis about mitochondrial activity, not a cellular measurement. exposure: Copper(I) and copper(II) binding energies, pKa and hydrophilicity evidence_span: {"source_cache": "artifacts/metformin-research/24433134.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a6dda36e30a49ba48e8200b6de36f39a8ab80a1bcbda819c03d3442bb8705963", "start_char": 0, "end_char": 1430, "text_sha256": "a6dda36e30a49ba48e8200b6de36f39a8ab80a1bcbda819c03d3442bb8705963"} [metformin-p24433134] Biomolecular mode of action of metformin in relation to its copper binding properties. (2014). https://pubmed.ncbi.nlm.nih.gov/24433134/ DOI: 10.1021/bi401444n
Complete structured claim and evidence
Where it participates (unsigned role)
CGA at 0.5 micromolar inhibited copper-induced LDL oxidation during initiation.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chlorogenic_acid-research/9089288.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "459e8c9d21cadd0d8e0cd76d596dd8b6deb9c373fb7d4ee9efb8e8f507ed03ff", "start_char": 0, "end_char": 1419, "text_sha256": "459e8c9d21cadd0d8e0cd76d596dd8b6deb9c373fb7d4ee9efb8e8f507ed03ff"}
- experimental_model
- Isolated human LDL oxidation with copper challenge
- exposure
- CGA 0.5 micromolar at initiation; 0.1 micromolar or more during propagation
- limitations
- Reaction phase and concentration determine direction. This does not show that dietary CGA plus copper produces vascular harm. More detailed caffeic-acid timing and concentration findings must not be transferred to CGA.
- nutrient_topic
- Chlorogenic acid research collection; topical membership is not evidence of a direct dietary effect. · Chlorogenic acid / 5-O-caffeoylquinic acid
- organism
- Human LDL outside the body
- plain_language
- The early reaction stage showed antioxidant behavior.
- primary_references
- [chlorogenic_acid-p9089288] Prooxidant activity of caffeic acid, dietary non-flavonoid phenolic acid, on Cu2+-induced low density lipoprotein oxidation. (1997). https://pubmed.ncbi.nlm.nih.gov/9089288/ DOI: 10.1016/s0014-5793(97)00185-3
- tissue_or_cell_type
- LDL oxidation initiation versus propagation
Chlorogenic acid: metabolism, signaling and nutrient connections (2026-09-17) · lines 737–748
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Isolated human LDL oxidation with copper challenge · source_derived_draft · unverified_draft
### chlorogenic_acid-ldl-initiation CGA at 0.5 micromolar inhibited copper-induced LDL oxidation during initiation. Condition category: normal nutrient_topic: Chlorogenic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: The early reaction stage showed antioxidant behavior. organism: Human LDL outside the body tissue_or_cell_type: LDL oxidation initiation versus propagation experimental_model: Isolated human LDL oxidation with copper challenge limitations: Reaction phase and concentration determine direction. This does not show that dietary CGA plus copper produces vascular harm. More detailed caffeic-acid timing and concentration findings must not be transferred to CGA. exposure: CGA 0.5 micromolar at initiation; 0.1 micromolar or more during propagation evidence_span: {"source_cache": "artifacts/chlorogenic_acid-research/9089288.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "459e8c9d21cadd0d8e0cd76d596dd8b6deb9c373fb7d4ee9efb8e8f507ed03ff", "start_char": 0, "end_char": 1419, "text_sha256": "459e8c9d21cadd0d8e0cd76d596dd8b6deb9c373fb7d4ee9efb8e8f507ed03ff"} [chlorogenic_acid-p9089288] Prooxidant activity of caffeic acid, dietary non-flavonoid phenolic acid, on Cu2+-induced low density lipoprotein oxidation. (1997). https://pubmed.ncbi.nlm.nih.gov/9089288/ DOI: 10.1016/s0014-5793(97)00185-3
Complete structured claim and evidenceCGA at 0.1 micromolar or more enhanced LDL oxidation during propagation.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chlorogenic_acid-research/9089288.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "459e8c9d21cadd0d8e0cd76d596dd8b6deb9c373fb7d4ee9efb8e8f507ed03ff", "start_char": 0, "end_char": 1419, "text_sha256": "459e8c9d21cadd0d8e0cd76d596dd8b6deb9c373fb7d4ee9efb8e8f507ed03ff"}
- experimental_model
- Isolated human LDL oxidation with copper challenge
- exposure
- CGA 0.5 micromolar at initiation; 0.1 micromolar or more during propagation
- limitations
- Reaction phase and concentration determine direction. This does not show that dietary CGA plus copper produces vascular harm. More detailed caffeic-acid timing and concentration findings must not be transferred to CGA.
- nutrient_topic
- Chlorogenic acid research collection; topical membership is not evidence of a direct dietary effect. · Chlorogenic acid / 5-O-caffeoylquinic acid
- organism
- Human LDL outside the body
- plain_language
- Once oxidation was underway, the direction differed.
- primary_references
- [chlorogenic_acid-p9089288] Prooxidant activity of caffeic acid, dietary non-flavonoid phenolic acid, on Cu2+-induced low density lipoprotein oxidation. (1997). https://pubmed.ncbi.nlm.nih.gov/9089288/ DOI: 10.1016/s0014-5793(97)00185-3
- tissue_or_cell_type
- LDL oxidation initiation versus propagation
Chlorogenic acid: metabolism, signaling and nutrient connections (2026-09-17) · lines 750–761
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Isolated human LDL oxidation with copper challenge · source_derived_draft · unverified_draft
### chlorogenic_acid-ldl-propagation CGA at 0.1 micromolar or more enhanced LDL oxidation during propagation. Condition category: normal nutrient_topic: Chlorogenic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: Once oxidation was underway, the direction differed. organism: Human LDL outside the body tissue_or_cell_type: LDL oxidation initiation versus propagation experimental_model: Isolated human LDL oxidation with copper challenge limitations: Reaction phase and concentration determine direction. This does not show that dietary CGA plus copper produces vascular harm. More detailed caffeic-acid timing and concentration findings must not be transferred to CGA. exposure: CGA 0.5 micromolar at initiation; 0.1 micromolar or more during propagation evidence_span: {"source_cache": "artifacts/chlorogenic_acid-research/9089288.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "459e8c9d21cadd0d8e0cd76d596dd8b6deb9c373fb7d4ee9efb8e8f507ed03ff", "start_char": 0, "end_char": 1419, "text_sha256": "459e8c9d21cadd0d8e0cd76d596dd8b6deb9c373fb7d4ee9efb8e8f507ed03ff"} [chlorogenic_acid-p9089288] Prooxidant activity of caffeic acid, dietary non-flavonoid phenolic acid, on Cu2+-induced low density lipoprotein oxidation. (1997). https://pubmed.ncbi.nlm.nih.gov/9089288/ DOI: 10.1016/s0014-5793(97)00185-3
Complete structured claim and evidenceLower Mg intake increased supraventricular ectopy in a randomized crossover feeding study of postmenopausal women.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence-system
- 22 completers; 81-day low and supplemented Mg periods; Holter monitoring
- experimental_model
- 22 completers; 81-day low and supplemented Mg periods; Holter monitoring
- exposure
- Chemically measured mean intake: 130 mg Mg/day in the low period versus 411 mg/day in the supplemented period; 81 days per period after 10-day equilibration. These are experimental exposures, not recommendations.
- limitations
- Ventricular ectopy alone was not significantly increased; small cohort. Dietary copper varied independently; reported Mg effect was unaffected by copper or sequence.
- nutrient_topic
- Magnesium research collection; topical membership is not evidence of a direct dietary effect. · Magnesium
- organism
- Human
- plain_language
- Controlled magnesium restriction produced its own measurable cardiac electrical effect.
- primary_references
- [klevay-2002-ectopy] Low dietary magnesium increases supraventricular ectopy (2002). https://ajcn.nutrition.org/article/S0002-9165%2823%2906154-3/fulltext DOI: 10.1093/ajcn/75.3.550
- tissue
- Whole-body nutrition; cardiac electrophysiology
- tissue_or_cell_type
- Whole-body nutrition; cardiac electrophysiology
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Magnesium: cross-nutrient mechanisms and deficiency (2026-09-17) · lines 1318–1330
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · 22 completers; 81-day low and supplemented Mg periods; Holter monitoring · source_derived_draft · unverified_draft
### low-dietary-magnesium-increases-ectopy Lower Mg intake increased supraventricular ectopy in a randomized crossover feeding study of postmenopausal women. Condition category: nutrient_deficiency nutrient_topic: Magnesium research collection; topical membership is not evidence of a direct dietary effect. plain_language: Controlled magnesium restriction produced its own measurable cardiac electrical effect. organism: Human tissue_or_cell_type: Whole-body nutrition; cardiac electrophysiology experimental_model: 22 completers; 81-day low and supplemented Mg periods; Holter monitoring limitations: Ventricular ectopy alone was not significantly increased; small cohort. Dietary copper varied independently; reported Mg effect was unaffected by copper or sequence. exposure: Chemically measured mean intake: 130 mg Mg/day in the low period versus 411 mg/day in the supplemented period; 81 days per period after 10-day equilibration. These are experimental exposures, not recommendations. evidence-system: 22 completers; 81-day low and supplemented Mg periods; Holter monitoring tissue: Whole-body nutrition; cardiac electrophysiology [klevay-2002-ectopy] Low dietary magnesium increases supraventricular ectopy (2002). https://ajcn.nutrition.org/article/S0002-9165%2823%2906154-3/fulltext DOI: 10.1093/ajcn/75.3.550
Complete structured claim and evidenceLuteolin–copper coordination suppressed radical formation and luteolin dose-dependently protected DNA in the Cu-Fenton assay.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- EPR spin trapping and DNA gel electrophoresis.
- limitations
- Neither cancer prevention nor clinical copper depletion follows from this assay.
- nutrient_topic
- Luteolin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Luteolin / 3′,4′,5,7-tetrahydroxyflavone
- plain_language
- This chemical assay showed protection rather than inevitable metal-driven damage.
- primary_references
- The effect of Luteolin on DNA damage mediated by a copper catalyzed Fenton reaction. · 2022 · https://pubmed.ncbi.nlm.nih.gov/34717250/ · DOI 10.1016/j.jinorgbio.2021.111635
Luteolin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 324–330
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · EPR spin trapping and DNA gel electrophoresis. · source_derived_draft · unverified_draft
## luteolin-copper-fenton This chemical assay showed protection rather than inevitable metal-driven damage. Luteolin–copper coordination suppressed radical formation and luteolin dose-dependently protected DNA in the Cu-Fenton assay. Model: EPR spin trapping and DNA gel electrophoresis. Limitations: Neither cancer prevention nor clinical copper depletion follows from this assay. Evidence access: Primary abstract The effect of Luteolin on DNA damage mediated by a copper catalyzed Fenton reaction. · 2022 · https://pubmed.ncbi.nlm.nih.gov/34717250/ · DOI 10.1016/j.jinorgbio.2021.111635
Complete structured claim and evidenceWith ascorbate present, resveratrol protected DNA in copper-based chemical experiments without lowering hydroxyl-radical formation rate, consistent with radical scavenging.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cell-free DNA-bound copper system.
- limitations
- Authors inferred physiological relevance; this experiment does not establish systemic safety or clinical synergy.
- nutrient_topic
- Resveratrol collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Resveratrol
- plain_language
- Vitamin C changes the relevant chemical context.
- primary_references
- Effects of trans-resveratrol on copper-dependent hydroxyl-radical formation and DNA damage: evidence for hydroxyl-radical scavenging and a novel, glutathione-sparing mechanism of action. · 2000 · https://pubmed.ncbi.nlm.nih.gov/11032413/ · DOI 10.1006/abbi.2000.1973
Resveratrol: metabolites, target selectivity and cross-nutrient mechanisms (2026-09-19) · lines 374–380
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Cell-free DNA-bound copper system. · source_derived_draft · unverified_draft
## resveratrol-ascorbate-context Vitamin C changes the relevant chemical context. With ascorbate present, resveratrol protected DNA in copper-based chemical experiments without lowering hydroxyl-radical formation rate, consistent with radical scavenging. Model: Cell-free DNA-bound copper system. Limitations: Authors inferred physiological relevance; this experiment does not establish systemic safety or clinical synergy. Evidence access: Primary abstract Effects of trans-resveratrol on copper-dependent hydroxyl-radical formation and DNA damage: evidence for hydroxyl-radical scavenging and a novel, glutathione-sparing mechanism of action. · 2000 · https://pubmed.ncbi.nlm.nih.gov/11032413/ · DOI 10.1006/abbi.2000.1973
Complete structured claim and evidenceCopper-specific chelators, unlike tested iron/zinc chelators, inhibited resveratrol-associated DNA breakage in isolated human lymphocyte and nuclear experiments.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Isolated cells, permeabilized cells and nuclei.
- limitations
- Cancer-selective killing was a proposed interpretation, not demonstrated clinical benefit.
- nutrient_topic
- Resveratrol collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Resveratrol
- plain_language
- A metal-specific rescue helps identify the assay mechanism.
- primary_references
- Resveratrol mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for chemoprevention of cancer. · 2010 · https://pubmed.ncbi.nlm.nih.gov/20119749/ · DOI 10.1007/s11095-010-0055-4
Resveratrol: metabolites, target selectivity and cross-nutrient mechanisms (2026-09-19) · lines 390–396
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Isolated cells, permeabilized cells and nuclei. · source_derived_draft · unverified_draft
## resveratrol-copper-chelator-rescue A metal-specific rescue helps identify the assay mechanism. Copper-specific chelators, unlike tested iron/zinc chelators, inhibited resveratrol-associated DNA breakage in isolated human lymphocyte and nuclear experiments. Model: Isolated cells, permeabilized cells and nuclei. Limitations: Cancer-selective killing was a proposed interpretation, not demonstrated clinical benefit. Evidence access: Primary abstract Resveratrol mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for chemoprevention of cancer. · 2010 · https://pubmed.ncbi.nlm.nih.gov/20119749/ · DOI 10.1007/s11095-010-0055-4
Complete structured claim and evidenceResveratrol/copper treatment produced plasmid sequence mutations and reduced transformation efficiency in a cell-free DNA/bacterial readout experiment.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Plasmid treatment followed by E. coli transformation/sequencing.
- limitations
- Not demonstrated human mutagenicity from dietary resveratrol.
- nutrient_topic
- Resveratrol collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Resveratrol
- plain_language
- Copper can change an antioxidant into a pro-oxidant in an assay.
- primary_references
- Prooxidant activity of resveratrol in the presence of copper ions: mutagenicity in plasmid DNA. · 2005 · https://pubmed.ncbi.nlm.nih.gov/15913925/ · DOI 10.1016/j.toxlet.2005.04.001
Resveratrol: metabolites, target selectivity and cross-nutrient mechanisms (2026-09-19) · lines 366–372
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Plasmid treatment followed by E. coli transformation/sequencing. · source_derived_draft · unverified_draft
## resveratrol-copper-dna Copper can change an antioxidant into a pro-oxidant in an assay. Resveratrol/copper treatment produced plasmid sequence mutations and reduced transformation efficiency in a cell-free DNA/bacterial readout experiment. Model: Plasmid treatment followed by E. coli transformation/sequencing. Limitations: Not demonstrated human mutagenicity from dietary resveratrol. Evidence access: Primary abstract Prooxidant activity of resveratrol in the presence of copper ions: mutagenicity in plasmid DNA. · 2005 · https://pubmed.ncbi.nlm.nih.gov/15913925/ · DOI 10.1016/j.toxlet.2005.04.001
Complete structured claim and evidenceIn the glutathione-containing copper system, resveratrol reduced radical formation and glutathione-disulfide formation.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Chemical assay with glutathione versus ascorbate conditions.
- limitations
- Not a measurement of GSH synthesis, recycling or depletion in humans.
- nutrient_topic
- Resveratrol collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Resveratrol
- plain_language
- Glutathione changes the redox reaction rather than merely adding another antioxidant label.
- primary_references
- Effects of trans-resveratrol on copper-dependent hydroxyl-radical formation and DNA damage: evidence for hydroxyl-radical scavenging and a novel, glutathione-sparing mechanism of action. · 2000 · https://pubmed.ncbi.nlm.nih.gov/11032413/ · DOI 10.1006/abbi.2000.1973
Resveratrol: metabolites, target selectivity and cross-nutrient mechanisms (2026-09-19) · lines 382–388
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Chemical assay with glutathione versus ascorbate conditions. · source_derived_draft · unverified_draft
## resveratrol-gsh-context Glutathione changes the redox reaction rather than merely adding another antioxidant label. In the glutathione-containing copper system, resveratrol reduced radical formation and glutathione-disulfide formation. Model: Chemical assay with glutathione versus ascorbate conditions. Limitations: Not a measurement of GSH synthesis, recycling or depletion in humans. Evidence access: Primary abstract Effects of trans-resveratrol on copper-dependent hydroxyl-radical formation and DNA damage: evidence for hydroxyl-radical scavenging and a novel, glutathione-sparing mechanism of action. · 2000 · https://pubmed.ncbi.nlm.nih.gov/11032413/ · DOI 10.1006/abbi.2000.1973
Complete structured claim and evidenceErgothioneine bound copper(I), rather than copper(II), and formed a redox-inactive complex in the tested chemical systems.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Spectroscopy and competition against histidine/phenanthroline.
- limitations
- This is not demonstrated copper depletion in humans.
- nutrient_topic
- Ergothioneine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · L-Ergothioneine
- plain_language
- Copper oxidation state matters for binding.
- primary_references
- Ergothioneine prevents copper-induced oxidative damage to DNA and protein by forming a redox-inactive ergothioneine-copper complex. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21047085/ · DOI 10.1021/tx100214t
Ergothioneine: transport, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 120–126
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Spectroscopy and competition against histidine/phenanthroline. · source_derived_draft · unverified_draft
## ergothioneine-copper-binding Copper oxidation state matters for binding. Ergothioneine bound copper(I), rather than copper(II), and formed a redox-inactive complex in the tested chemical systems. Model: Spectroscopy and competition against histidine/phenanthroline. Limitations: This is not demonstrated copper depletion in humans. Evidence access: Primary abstract Ergothioneine prevents copper-induced oxidative damage to DNA and protein by forming a redox-inactive ergothioneine-copper complex. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21047085/ · DOI 10.1021/tx100214t
Complete structured claim and evidenceErgothioneine at 0.1-1 mM protected DNA and albumin against 0.1 mM copper with ascorbate or peroxide.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cell-free copper/ascorbate and copper/peroxide systems.
- limitations
- Exposure and free-metal speciation limit extrapolation.
- nutrient_topic
- Ergothioneine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · L-Ergothioneine
- plain_language
- Binding the catalyst can protect several targets.
- primary_references
- Ergothioneine prevents copper-induced oxidative damage to DNA and protein by forming a redox-inactive ergothioneine-copper complex. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21047085/ · DOI 10.1021/tx100214t
Ergothioneine: transport, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 128–134
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Cell-free copper/ascorbate and copper/peroxide systems. · source_derived_draft · unverified_draft
## ergothioneine-copper-oxidation Binding the catalyst can protect several targets. Ergothioneine at 0.1-1 mM protected DNA and albumin against 0.1 mM copper with ascorbate or peroxide. Model: Cell-free copper/ascorbate and copper/peroxide systems. Limitations: Exposure and free-metal speciation limit extrapolation. Evidence access: Primary abstract Ergothioneine prevents copper-induced oxidative damage to DNA and protein by forming a redox-inactive ergothioneine-copper complex. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21047085/ · DOI 10.1021/tx100214t
Complete structured claim and evidenceLipoic acid did not prevent intracellular ascorbate loss caused by the extracellular copper/LDL challenge in the same study.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/ala-research/18026819.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a4dff4887489013858d07ce07ba538c62702962afa1588ae7cc83e308648e53a", "start_char": 0, "end_char": 1329, "text_sha256": "a4dff4887489013858d07ce07ba538c62702962afa1588ae7cc83e308648e53a"}
- experimental_model
- Human endothelial-cell and extracellular LDL oxidation experiments
- exposure
- 40–80 micromolar lipoic acid; menadione or copper/LDL challenge
- limitations
- Compartment and oxidant matter; intracellular vitamin C and LDL vitamin E are distinct readouts.
- nutrient_topic
- Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. · Lipoic acid
- organism
- Human cell line and human LDL
- plain_language
- Protection of LDL did not guarantee protection of intracellular vitamin C.
- primary_references
- [ala-p18026819] alpha-Lipoic acid and ascorbate prevent LDL oxidation and oxidant stress in endothelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18026819/ DOI: 10.1007/s11010-007-9650-z
- tissue_or_cell_type
- EA.hy926 endothelial cells; extracellular LDL
Alpha-lipoic acid: cofactor assembly, redox signaling and nutrient interactions (2026-09-17) · lines 1027–1038
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human endothelial-cell and extracellular LDL oxidation experiments · source_derived_draft · unverified_draft
### ala-copper-challenge-ascorbate-null Lipoic acid did not prevent intracellular ascorbate loss caused by the extracellular copper/LDL challenge in the same study. Condition category: normal nutrient_topic: Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: Protection of LDL did not guarantee protection of intracellular vitamin C. organism: Human cell line and human LDL tissue_or_cell_type: EA.hy926 endothelial cells; extracellular LDL experimental_model: Human endothelial-cell and extracellular LDL oxidation experiments limitations: Compartment and oxidant matter; intracellular vitamin C and LDL vitamin E are distinct readouts. exposure: 40–80 micromolar lipoic acid; menadione or copper/LDL challenge evidence_span: {"source_cache": "artifacts/ala-research/18026819.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a4dff4887489013858d07ce07ba538c62702962afa1588ae7cc83e308648e53a", "start_char": 0, "end_char": 1329, "text_sha256": "a4dff4887489013858d07ce07ba538c62702962afa1588ae7cc83e308648e53a"} [ala-p18026819] alpha-Lipoic acid and ascorbate prevent LDL oxidation and oxidant stress in endothelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18026819/ DOI: 10.1007/s11010-007-9650-z
Complete structured claim and evidenceOxidation destabilized DHLA-copper complexes near physiological pH, with renewed LDL oxidation and radical detection in the model.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/ala-research/9680174.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ac15770e92102947345520296b7795e8ff2dca2c345ac76c14b929fbd19739f1", "start_char": 0, "end_char": 2034, "text_sha256": "ac15770e92102947345520296b7795e8ff2dca2c345ac76c14b929fbd19739f1"}
- experimental_model
- Cell-free human LDL oxidation and electron-spin-resonance assays
- exposure
- Copper 5 micromolar; DHLA 0–20 micromolar; oxygen and pH varied
- limitations
- Metal binding, reduction and radical production depend on ratio, oxygen and pH; not evidence for human metal-detoxification efficacy.
- nutrient_topic
- Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. · Lipoic acid
- organism
- Human LDL; cell-free chemistry
- plain_language
- Metal binding was not a permanent guarantee against oxidation.
- primary_references
- [ala-p9680174] Thiol chelation of Cu2+ by dihydrolipoic acid prevents human low density lipoprotein peroxidation. (1998). https://pubmed.ncbi.nlm.nih.gov/9680174/ DOI: 10.1016/s0891-5849(98)00048-3
- tissue_or_cell_type
- LDL and copper/DHLA solutions
Alpha-lipoic acid: cofactor assembly, redox signaling and nutrient interactions (2026-09-17) · lines 1066–1077
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell-free human LDL oxidation and electron-spin-resonance assays · source_derived_draft · unverified_draft
### ala-dhla-copper-oxygen Oxidation destabilized DHLA-copper complexes near physiological pH, with renewed LDL oxidation and radical detection in the model. Condition category: normal nutrient_topic: Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: Metal binding was not a permanent guarantee against oxidation. organism: Human LDL; cell-free chemistry tissue_or_cell_type: LDL and copper/DHLA solutions experimental_model: Cell-free human LDL oxidation and electron-spin-resonance assays limitations: Metal binding, reduction and radical production depend on ratio, oxygen and pH; not evidence for human metal-detoxification efficacy. exposure: Copper 5 micromolar; DHLA 0–20 micromolar; oxygen and pH varied evidence_span: {"source_cache": "artifacts/ala-research/9680174.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ac15770e92102947345520296b7795e8ff2dca2c345ac76c14b929fbd19739f1", "start_char": 0, "end_char": 2034, "text_sha256": "ac15770e92102947345520296b7795e8ff2dca2c345ac76c14b929fbd19739f1"} [ala-p9680174] Thiol chelation of Cu2+ by dihydrolipoic acid prevents human low density lipoprotein peroxidation. (1998). https://pubmed.ncbi.nlm.nih.gov/9680174/ DOI: 10.1016/s0891-5849(98)00048-3
Complete structured claim and evidenceDHLA delayed copper-driven LDL oxidation, whereas oxidized lipoic acid did not protect in this cell-free assay.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/ala-research/9680174.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ac15770e92102947345520296b7795e8ff2dca2c345ac76c14b929fbd19739f1", "start_char": 0, "end_char": 2034, "text_sha256": "ac15770e92102947345520296b7795e8ff2dca2c345ac76c14b929fbd19739f1"}
- experimental_model
- Cell-free human LDL oxidation and electron-spin-resonance assays
- exposure
- Copper 5 micromolar; DHLA 0–20 micromolar; oxygen and pH varied
- limitations
- Metal binding, reduction and radical production depend on ratio, oxygen and pH; not evidence for human metal-detoxification efficacy.
- nutrient_topic
- Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. · Lipoic acid
- organism
- Human LDL; cell-free chemistry
- plain_language
- Reduced and oxidized forms behaved differently in the same chemical test.
- primary_references
- [ala-p9680174] Thiol chelation of Cu2+ by dihydrolipoic acid prevents human low density lipoprotein peroxidation. (1998). https://pubmed.ncbi.nlm.nih.gov/9680174/ DOI: 10.1016/s0891-5849(98)00048-3
- tissue_or_cell_type
- LDL and copper/DHLA solutions
Alpha-lipoic acid: cofactor assembly, redox signaling and nutrient interactions (2026-09-17) · lines 1040–1051
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cell-free human LDL oxidation and electron-spin-resonance assays · source_derived_draft · unverified_draft
### ala-dhla-ldl-protection DHLA delayed copper-driven LDL oxidation, whereas oxidized lipoic acid did not protect in this cell-free assay. Condition category: normal nutrient_topic: Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: Reduced and oxidized forms behaved differently in the same chemical test. organism: Human LDL; cell-free chemistry tissue_or_cell_type: LDL and copper/DHLA solutions experimental_model: Cell-free human LDL oxidation and electron-spin-resonance assays limitations: Metal binding, reduction and radical production depend on ratio, oxygen and pH; not evidence for human metal-detoxification efficacy. exposure: Copper 5 micromolar; DHLA 0–20 micromolar; oxygen and pH varied evidence_span: {"source_cache": "artifacts/ala-research/9680174.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ac15770e92102947345520296b7795e8ff2dca2c345ac76c14b929fbd19739f1", "start_char": 0, "end_char": 2034, "text_sha256": "ac15770e92102947345520296b7795e8ff2dca2c345ac76c14b929fbd19739f1"} [ala-p9680174] Thiol chelation of Cu2+ by dihydrolipoic acid prevents human low density lipoprotein peroxidation. (1998). https://pubmed.ncbi.nlm.nih.gov/9680174/ DOI: 10.1016/s0891-5849(98)00048-3
Complete structured claim and evidenceLipoic acid blunted copper-driven LDL oxidation and associated vitamin E consumption in the endothelial-cell experiment.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/ala-research/18026819.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a4dff4887489013858d07ce07ba538c62702962afa1588ae7cc83e308648e53a", "start_char": 0, "end_char": 1329, "text_sha256": "a4dff4887489013858d07ce07ba538c62702962afa1588ae7cc83e308648e53a"}
- experimental_model
- Human endothelial-cell and extracellular LDL oxidation experiments
- exposure
- 40–80 micromolar lipoic acid; menadione or copper/LDL challenge
- limitations
- Compartment and oxidant matter; intracellular vitamin C and LDL vitamin E are distinct readouts.
- nutrient_topic
- Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. · Lipoic acid
- organism
- Human cell line and human LDL
- plain_language
- The extracellular lipoprotein compartment showed less oxidative damage.
- primary_references
- [ala-p18026819] alpha-Lipoic acid and ascorbate prevent LDL oxidation and oxidant stress in endothelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18026819/ DOI: 10.1007/s11010-007-9650-z
- tissue_or_cell_type
- EA.hy926 endothelial cells; extracellular LDL
Alpha-lipoic acid: cofactor assembly, redox signaling and nutrient interactions (2026-09-17) · lines 1014–1025
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human endothelial-cell and extracellular LDL oxidation experiments · source_derived_draft · unverified_draft
### ala-ldl-vitamin-e-sparing Lipoic acid blunted copper-driven LDL oxidation and associated vitamin E consumption in the endothelial-cell experiment. Condition category: normal nutrient_topic: Alpha-lipoic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: The extracellular lipoprotein compartment showed less oxidative damage. organism: Human cell line and human LDL tissue_or_cell_type: EA.hy926 endothelial cells; extracellular LDL experimental_model: Human endothelial-cell and extracellular LDL oxidation experiments limitations: Compartment and oxidant matter; intracellular vitamin C and LDL vitamin E are distinct readouts. exposure: 40–80 micromolar lipoic acid; menadione or copper/LDL challenge evidence_span: {"source_cache": "artifacts/ala-research/18026819.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a4dff4887489013858d07ce07ba538c62702962afa1588ae7cc83e308648e53a", "start_char": 0, "end_char": 1329, "text_sha256": "a4dff4887489013858d07ce07ba538c62702962afa1588ae7cc83e308648e53a"} [ala-p18026819] alpha-Lipoic acid and ascorbate prevent LDL oxidation and oxidant stress in endothelial cells. (2008). https://pubmed.ncbi.nlm.nih.gov/18026819/ DOI: 10.1007/s11010-007-9650-z
Complete structured claim and evidenceAdding reduced glutathione reversed copper inhibition of the reconstituted native rat carnitine-acylcarnitine carrier.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Rat-liver CACT proteoliposome assay.
- limitations
- Does not demonstrate oral glutathione-carnitine synergy.
- nutrient_topic
- L-Carnitine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnitine
- plain_language
- The redox environment can change whether the carrier works.
- primary_references
- Effect of Copper on the Mitochondrial Carnitine/Acylcarnitine Carrier Via Interaction with Cys136 and Cys155. Possible Implications in Pathophysiology. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32070004/ · DOI 10.3390/molecules25040820
L-Carnitine: synthesis, acyl-group transport, fuel selection and nutrient interactions (2026-09-19) · lines 146–152
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Rat-liver CACT proteoliposome assay. · source_derived_draft · unverified_draft
## l-carnitine-gsh-carrier The redox environment can change whether the carrier works. Adding reduced glutathione reversed copper inhibition of the reconstituted native rat carnitine-acylcarnitine carrier. Model: Rat-liver CACT proteoliposome assay. Limitations: Does not demonstrate oral glutathione-carnitine synergy. Evidence access: Primary abstract Effect of Copper on the Mitochondrial Carnitine/Acylcarnitine Carrier Via Interaction with Cys136 and Cys155. Possible Implications in Pathophysiology. · 2020 · https://pubmed.ncbi.nlm.nih.gov/32070004/ · DOI 10.3390/molecules25040820
Complete structured claim and evidenceCoexpression of CCS increased Cu(I) incorporation into SOD1 after Cu(II) exposure in zinc-supplemented HEK293T cells; at higher expression the Cu(I),Zn-SOD1:E,Zn-SOD1 ratio reached about 1:1.
Experimental context and source evidence
- cross_nutrient
- true
- experimental_model
- Transient expression of human SOD1 and CCS in human HEK293T cells; in-cell NMR
- exposure
- 10 µM ZnSO4 in expression medium; 100 µM CuCl2 added after 48 h and incubated 24 h.
- limitations
- HEK293T cells overexpressed SOD1/CCS above endogenous levels; these medium concentrations are experimental exposures, not dietary targets. Copper transfer and disulfide oxidation need not occur in a fixed coupled step in every cellular context.
- nutrient_topic
- Zinc research collection; topical membership is not evidence of a direct dietary effect. · Zinc
- organism
- Homo sapiens
- plain_language
- The copper chaperone increased copper loading into zinc-containing SOD1.
- primary_references
- [zinc-enz-sod1-live2013] Atomic-resolution monitoring of protein maturation in live human cells by NMR. (2013). https://pubmed.ncbi.nlm.nih.gov/23455544/ DOI: 10.1038/nchembio.1202
- tissue_or_cell_type
- Human HEK293T cytoplasm
Zinc: transport, enzyme loading, deficiency and nutrient interactions (2026-09-17) · lines 742–753
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transient expression of human SOD1 and CCS in human HEK293T cells; in-cell NMR · source_derived_draft · unverified_draft
### zinc-enz-sod1-copper-loading Coexpression of CCS increased Cu(I) incorporation into SOD1 after Cu(II) exposure in zinc-supplemented HEK293T cells; at higher expression the Cu(I),Zn-SOD1:E,Zn-SOD1 ratio reached about 1:1. Condition category: normal nutrient_topic: Zinc research collection; topical membership is not evidence of a direct dietary effect. plain_language: The copper chaperone increased copper loading into zinc-containing SOD1. organism: Homo sapiens tissue_or_cell_type: Human HEK293T cytoplasm experimental_model: Transient expression of human SOD1 and CCS in human HEK293T cells; in-cell NMR limitations: HEK293T cells overexpressed SOD1/CCS above endogenous levels; these medium concentrations are experimental exposures, not dietary targets. Copper transfer and disulfide oxidation need not occur in a fixed coupled step in every cellular context. exposure: 10 µM ZnSO4 in expression medium; 100 µM CuCl2 added after 48 h and incubated 24 h. cross_nutrient: true [zinc-enz-sod1-live2013] Atomic-resolution monitoring of protein maturation in live human cells by NMR. (2013). https://pubmed.ncbi.nlm.nih.gov/23455544/ DOI: 10.1038/nchembio.1202
Complete structured claim and evidenceMouse ZIP14 did not increase uptake of radiolabeled copper supplied as Cu(I) or Cu(II) in the tested oocyte conditions.
Experimental context and source evidence
- cross_nutrient
- true
- experimental_model
- Radiolabeled Cu(I) and Cu(II) uptake in Xenopus oocytes
- exposure
- Cu(I) and Cu(II) tested separately against controls.
- limitations
- A bounded negative result does not mean zinc and copper have no interaction through other proteins or intestinal mechanisms.
- nutrient_topic
- Zinc research collection; topical membership is not evidence of a direct dietary effect. · Zinc
- organism
- Mouse protein in Xenopus laevis oocytes
- plain_language
- This ZIP14 experiment found no copper transport despite detecting other metal substrates.
- primary_references
- [zinc-trans-21653899] Zip14 is a complex broad-scope metal-ion transporter whose functional properties support roles in the cellular uptake of zinc and nontransferrin-bound iron. (2011). https://pubmed.ncbi.nlm.nih.gov/21653899/ DOI: 10.1152/ajpcell.00479.2010
- tissue_or_cell_type
- Oocyte plasma membrane
Zinc: transport, enzyme loading, deficiency and nutrient interactions (2026-09-17) · lines 518–529
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Radiolabeled Cu(I) and Cu(II) uptake in Xenopus oocytes · source_derived_draft · unverified_draft
### zinc-trans-zip14-copper-negative Mouse ZIP14 did not increase uptake of radiolabeled copper supplied as Cu(I) or Cu(II) in the tested oocyte conditions. Condition category: normal nutrient_topic: Zinc research collection; topical membership is not evidence of a direct dietary effect. plain_language: This ZIP14 experiment found no copper transport despite detecting other metal substrates. organism: Mouse protein in Xenopus laevis oocytes tissue_or_cell_type: Oocyte plasma membrane experimental_model: Radiolabeled Cu(I) and Cu(II) uptake in Xenopus oocytes limitations: A bounded negative result does not mean zinc and copper have no interaction through other proteins or intestinal mechanisms. exposure: Cu(I) and Cu(II) tested separately against controls. cross_nutrient: true [zinc-trans-21653899] Zip14 is a complex broad-scope metal-ion transporter whose functional properties support roles in the cellular uptake of zinc and nontransferrin-bound iron. (2011). https://pubmed.ncbi.nlm.nih.gov/21653899/ DOI: 10.1152/ajpcell.00479.2010
Complete structured claim and evidenceA prepared 1:2 copper(II):fisetin complex cleaved and degraded DNA in chemical assays.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- DNA electrophoresis and spectroscopic assays.
- limitations
- Prepared complex exposure is not equivalent to eating copper-containing food with fisetin.
- nutrient_topic
- Fisetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Fisetin
- plain_language
- Metal binding does not guarantee antioxidant protection.
- primary_references
- Physicochemical, antioxidant, DNA cleaving properties and antimicrobial activity of fisetin-copper chelates. · 2018 · https://pubmed.ncbi.nlm.nih.gov/29247867/ · DOI 10.1016/j.jinorgbio.2017.12.006
Fisetin: metabolism, cell-state responses and cross-nutrient mechanisms (2026-09-19) · lines 144–150
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · DNA electrophoresis and spectroscopic assays. · source_derived_draft · unverified_draft
## fisetin-copper-dna-chemistry Metal binding does not guarantee antioxidant protection. A prepared 1:2 copper(II):fisetin complex cleaved and degraded DNA in chemical assays. Model: DNA electrophoresis and spectroscopic assays. Limitations: Prepared complex exposure is not equivalent to eating copper-containing food with fisetin. Evidence access: Primary abstract Physicochemical, antioxidant, DNA cleaving properties and antimicrobial activity of fisetin-copper chelates. · 2018 · https://pubmed.ncbi.nlm.nih.gov/29247867/ · DOI 10.1016/j.jinorgbio.2017.12.006
Complete structured claim and evidenceIn mouse HT22 cells, added iron reduced fisetin-induced nuclear Nrf2 and ATF4 from an iron:fisetin ratio of 0.5:1; copper did not do so in the tested range.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- 5 micromolar fisetin with FeCl2/CuCl2 titration.
- limitations
- Cell-culture ratio, not a clinical spacing rule for supplements.
- nutrient_topic
- Fisetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Fisetin
- plain_language
- Iron weakened the signaling response under these conditions.
- primary_references
- Modulation of the Neuroprotective and Anti-inflammatory Activities of the Flavonol Fisetin by the Transition Metals Iron and Copper. · 2020 · https://pubmed.ncbi.nlm.nih.gov/33187316/ · DOI 10.3390/antiox9111113
Fisetin: metabolism, cell-state responses and cross-nutrient mechanisms (2026-09-19) · lines 160–166
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · 5 micromolar fisetin with FeCl2/CuCl2 titration. · source_derived_draft · unverified_draft
## fisetin-iron-signaling-antagonism Iron weakened the signaling response under these conditions. In mouse HT22 cells, added iron reduced fisetin-induced nuclear Nrf2 and ATF4 from an iron:fisetin ratio of 0.5:1; copper did not do so in the tested range. Model: 5 micromolar fisetin with FeCl2/CuCl2 titration. Limitations: Cell-culture ratio, not a clinical spacing rule for supplements. Evidence access: Primary full text Modulation of the Neuroprotective and Anti-inflammatory Activities of the Flavonol Fisetin by the Transition Metals Iron and Copper. · 2020 · https://pubmed.ncbi.nlm.nih.gov/33187316/ · DOI 10.3390/antiox9111113
Complete structured claim and evidenceAt 5 micromolar, fisetin limited iron- or copper-potentiated glutathione loss and cell death in glutamate-challenged mouse HT22 cells.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Mouse HT22 cells; separately added FeCl2/CuCl2, 0.5-10 micromolar.
- limitations
- Not a dietary deficiency experiment or evidence of systemic metal removal.
- nutrient_topic
- Fisetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Fisetin
- plain_language
- Protection depended on the way oxidative stress was induced.
- primary_references
- Modulation of the Neuroprotective and Anti-inflammatory Activities of the Flavonol Fisetin by the Transition Metals Iron and Copper. · 2020 · https://pubmed.ncbi.nlm.nih.gov/33187316/ · DOI 10.3390/antiox9111113
Fisetin: metabolism, cell-state responses and cross-nutrient mechanisms (2026-09-19) · lines 152–158
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse HT22 cells; separately added FeCl2/CuCl2, 0.5-10 micromolar. · source_derived_draft · unverified_draft
## fisetin-metal-gsh-protection Protection depended on the way oxidative stress was induced. At 5 micromolar, fisetin limited iron- or copper-potentiated glutathione loss and cell death in glutamate-challenged mouse HT22 cells. Model: Mouse HT22 cells; separately added FeCl2/CuCl2, 0.5-10 micromolar. Limitations: Not a dietary deficiency experiment or evidence of systemic metal removal. Evidence access: Primary full text Modulation of the Neuroprotective and Anti-inflammatory Activities of the Flavonol Fisetin by the Transition Metals Iron and Copper. · 2020 · https://pubmed.ncbi.nlm.nih.gov/33187316/ · DOI 10.3390/antiox9111113
Complete structured claim and evidenceFulvic exposure increased intestinal mucosal copper retention at six hours without markedly changing lumen-to-mucosa uptake.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Suckling-rat tracer study; water and formula matrices.
- limitations
- The abstract switches to Cd when describing circulatory absorption. That sentence is not silently treated as a verified copper result; no infant recommendation follows.
- nutrient_topic
- Fulvic acid collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Fulvic acid (heterogeneous humic fraction)
- plain_language
- Copper stayed in the intestinal lining longer.
- primary_references
- Intestinal absorption of copper from drinking water containing fulvic acids and an infant formula mixture studied in a suckling rat model. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10406087/ · DOI 10.1023/a:1009233802104
Fulvic acid: mixture identity, mineral chemistry, signaling and cross-nutrient mechanisms (2026-09-19) · lines 84–90
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Suckling-rat tracer study; water and formula matrices. · source_derived_draft · unverified_draft
## fulvic-acid-copper-retention Copper stayed in the intestinal lining longer. Fulvic exposure increased intestinal mucosal copper retention at six hours without markedly changing lumen-to-mucosa uptake. Model: Suckling-rat tracer study; water and formula matrices. Limitations: The abstract switches to Cd when describing circulatory absorption. That sentence is not silently treated as a verified copper result; no infant recommendation follows. Evidence access: Primary abstract Intestinal absorption of copper from drinking water containing fulvic acids and an infant formula mixture studied in a suckling rat model. · 1999 · https://pubmed.ncbi.nlm.nih.gov/10406087/ · DOI 10.1023/a:1009233802104
Complete structured claim and evidenceFulvoFeed at 300 or 500 mg C/L increased the subsequent copper-associated ROS response.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Zebrafish larvae; FulvoFeed for 96 hours, wash, then copper 50 micromolar for 2 hours; ROS fluorescence assay.
- limitations
- mg C/L expresses organic carbon, not supplement mass. Washing reduced direct external copper-complexation confounding. ROS is an indirect inflammatory endpoint; proposed radical/aromatic explanations were not isolated genetic or binding tests. This is a concentration-dependent result, not an unexplained contradiction with the lower-dose result.
- nutrient_topic
- Fulvic acid collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Fulvic acid (heterogeneous humic fraction)
- plain_language
- Higher tested exposures amplified the same stress readout.
- primary_references
- Modification of the chemically induced inflammation assay reveals the Janus face of a phenol rich fulvic acid. · 2022 · https://pubmed.ncbi.nlm.nih.gov/35393468/ · DOI 10.1038/s41598-022-09782-w
Fulvic acid: mixture identity, mineral chemistry, signaling and cross-nutrient mechanisms (2026-09-19) · lines 204–210
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Zebrafish larvae; FulvoFeed for 96 hours, wash, then copper 50 micromolar for 2 hours; ROS fluorescence assay. · source_derived_draft · unverified_draft
## fulvic-acid-zebrafish-high Higher tested exposures amplified the same stress readout. FulvoFeed at 300 or 500 mg C/L increased the subsequent copper-associated ROS response. Model: Zebrafish larvae; FulvoFeed for 96 hours, wash, then copper 50 micromolar for 2 hours; ROS fluorescence assay. Limitations: mg C/L expresses organic carbon, not supplement mass. Washing reduced direct external copper-complexation confounding. ROS is an indirect inflammatory endpoint; proposed radical/aromatic explanations were not isolated genetic or binding tests. This is a concentration-dependent result, not an unexplained contradiction with the lower-dose result. Evidence access: Primary full text Modification of the chemically induced inflammation assay reveals the Janus face of a phenol rich fulvic acid. · 2022 · https://pubmed.ncbi.nlm.nih.gov/35393468/ · DOI 10.1038/s41598-022-09782-w
Complete structured claim and evidenceFulvoFeed at 5 or 50 mg C/L reduced the subsequent copper-associated ROS response.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Zebrafish larvae; FulvoFeed for 96 hours, wash, then copper 50 micromolar for 2 hours; ROS fluorescence assay.
- limitations
- mg C/L expresses organic carbon, not supplement mass. Washing reduced direct external copper-complexation confounding. ROS is an indirect inflammatory endpoint; proposed radical/aromatic explanations were not isolated genetic or binding tests.
- nutrient_topic
- Fulvic acid collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Fulvic acid (heterogeneous humic fraction)
- plain_language
- Lower tested exposures dampened the stress readout.
- primary_references
- Modification of the chemically induced inflammation assay reveals the Janus face of a phenol rich fulvic acid. · 2022 · https://pubmed.ncbi.nlm.nih.gov/35393468/ · DOI 10.1038/s41598-022-09782-w
Fulvic acid: mixture identity, mineral chemistry, signaling and cross-nutrient mechanisms (2026-09-19) · lines 196–202
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Zebrafish larvae; FulvoFeed for 96 hours, wash, then copper 50 micromolar for 2 hours; ROS fluorescence assay. · source_derived_draft · unverified_draft
## fulvic-acid-zebrafish-low Lower tested exposures dampened the stress readout. FulvoFeed at 5 or 50 mg C/L reduced the subsequent copper-associated ROS response. Model: Zebrafish larvae; FulvoFeed for 96 hours, wash, then copper 50 micromolar for 2 hours; ROS fluorescence assay. Limitations: mg C/L expresses organic carbon, not supplement mass. Washing reduced direct external copper-complexation confounding. ROS is an indirect inflammatory endpoint; proposed radical/aromatic explanations were not isolated genetic or binding tests. Evidence access: Primary full text Modification of the chemically induced inflammation assay reveals the Janus face of a phenol rich fulvic acid. · 2022 · https://pubmed.ncbi.nlm.nih.gov/35393468/ · DOI 10.1038/s41598-022-09782-w
Complete structured claim and evidenceWith 0.5 mM CuSO4 and 10 micrograms/mL myricetin, ATP content fell to 43% of untreated control.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human SH-SY5Y cells, 24 hours; 10 micrograms/mL myricetin is about 31.4 micromolar.
- limitations
- High copper cell-culture challenge; not evidence that ordinary copper foods plus myricetin cause neuronal injury.
- nutrient_topic
- Myricetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Myricetin
- plain_language
- Copper changes the outcome of this redox-active compound.
- primary_references
- Neurotoxic Effect of Flavonol Myricetin in the Presence of Excess Copper. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33562817/ · DOI 10.3390/molecules26040845
Myricetin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 340–346
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human SH-SY5Y cells, 24 hours; 10 micrograms/mL myricetin is about 31.4 micromolar. · source_derived_draft · unverified_draft
## myricetin-copper-atp Copper changes the outcome of this redox-active compound. With 0.5 mM CuSO4 and 10 micrograms/mL myricetin, ATP content fell to 43% of untreated control. Model: Human SH-SY5Y cells, 24 hours; 10 micrograms/mL myricetin is about 31.4 micromolar. Limitations: High copper cell-culture challenge; not evidence that ordinary copper foods plus myricetin cause neuronal injury. Evidence access: Primary full text Neurotoxic Effect of Flavonol Myricetin in the Presence of Excess Copper. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33562817/ · DOI 10.3390/molecules26040845
Complete structured claim and evidenceMyricetin exacerbated copper-associated cell death, corroborated by metabolic and trypan-blue measurements.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human SH-SY5Y cells, 24 hours; 10 micrograms/mL myricetin is about 31.4 micromolar.
- limitations
- High copper cell-culture challenge; not evidence that ordinary copper foods plus myricetin cause neuronal injury.
- nutrient_topic
- Myricetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Myricetin
- plain_language
- Copper changes the outcome of this redox-active compound.
- primary_references
- Neurotoxic Effect of Flavonol Myricetin in the Presence of Excess Copper. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33562817/ · DOI 10.3390/molecules26040845
Myricetin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 348–354
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human SH-SY5Y cells, 24 hours; 10 micrograms/mL myricetin is about 31.4 micromolar. · source_derived_draft · unverified_draft
## myricetin-copper-death Copper changes the outcome of this redox-active compound. Myricetin exacerbated copper-associated cell death, corroborated by metabolic and trypan-blue measurements. Model: Human SH-SY5Y cells, 24 hours; 10 micrograms/mL myricetin is about 31.4 micromolar. Limitations: High copper cell-culture challenge; not evidence that ordinary copper foods plus myricetin cause neuronal injury. Evidence access: Primary full text Neurotoxic Effect of Flavonol Myricetin in the Presence of Excess Copper. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33562817/ · DOI 10.3390/molecules26040845
Complete structured claim and evidenceMyricetin did not further reduce the glutathione pool already lowered by copper in this SH-SY5Y experiment.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human cells; 0.5 mM CuSO4, up to 10 micrograms/mL myricetin.
- limitations
- Do not convert proposed thiol chemistry into measured GSH depletion.
- nutrient_topic
- Myricetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Myricetin
- plain_language
- More injury did not require a further measured fall in glutathione.
- primary_references
- Neurotoxic Effect of Flavonol Myricetin in the Presence of Excess Copper. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33562817/ · DOI 10.3390/molecules26040845
Myricetin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 356–362
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human cells; 0.5 mM CuSO4, up to 10 micrograms/mL myricetin. · source_derived_draft · unverified_draft
## myricetin-copper-gsh-null More injury did not require a further measured fall in glutathione. Myricetin did not further reduce the glutathione pool already lowered by copper in this SH-SY5Y experiment. Model: Human cells; 0.5 mM CuSO4, up to 10 micrograms/mL myricetin. Limitations: Do not convert proposed thiol chemistry into measured GSH depletion. Evidence access: Primary full text Neurotoxic Effect of Flavonol Myricetin in the Presence of Excess Copper. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33562817/ · DOI 10.3390/molecules26040845
Complete structured claim and evidenceL-type calcium-channel blockade with 10 micromolar nifedipine exacerbated death during copper/myricetin exposure.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Human SH-SY5Y pharmacological perturbation.
- limitations
- Channel subtype and causal downstream steps were not resolved; no human medication interaction established.
- nutrient_topic
- Myricetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Myricetin
- plain_language
- Changing calcium entry altered the response.
- primary_references
- Neurotoxic Effect of Flavonol Myricetin in the Presence of Excess Copper. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33562817/ · DOI 10.3390/molecules26040845
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Myricetin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 364–370
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human SH-SY5Y pharmacological perturbation. · source_derived_draft · unverified_draft
## myricetin-copper-nifedipine Changing calcium entry altered the response. L-type calcium-channel blockade with 10 micromolar nifedipine exacerbated death during copper/myricetin exposure. Model: Human SH-SY5Y pharmacological perturbation. Limitations: Channel subtype and causal downstream steps were not resolved; no human medication interaction established. Evidence access: Primary full text Neurotoxic Effect of Flavonol Myricetin in the Presence of Excess Copper. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33562817/ · DOI 10.3390/molecules26040845
Complete structured claim and evidenceMyricetin at 5–10 micrograms/mL increased ROS under 0.5 mM CuSO4 exposure.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Human SH-SY5Y cells, 24 hours; 10 micrograms/mL myricetin is about 31.4 micromolar.
- limitations
- High copper cell-culture challenge; not evidence that ordinary copper foods plus myricetin cause neuronal injury.
- nutrient_topic
- Myricetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Myricetin
- plain_language
- Copper changes the outcome of this redox-active compound.
- primary_references
- Neurotoxic Effect of Flavonol Myricetin in the Presence of Excess Copper. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33562817/ · DOI 10.3390/molecules26040845
Myricetin: metabolism, immune signaling, redox chemistry and cross-nutrient mechanisms (2026-09-19) · lines 332–338
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human SH-SY5Y cells, 24 hours; 10 micrograms/mL myricetin is about 31.4 micromolar. · source_derived_draft · unverified_draft
## myricetin-copper-ros Copper changes the outcome of this redox-active compound. Myricetin at 5–10 micrograms/mL increased ROS under 0.5 mM CuSO4 exposure. Model: Human SH-SY5Y cells, 24 hours; 10 micrograms/mL myricetin is about 31.4 micromolar. Limitations: High copper cell-culture challenge; not evidence that ordinary copper foods plus myricetin cause neuronal injury. Evidence access: Primary full text Neurotoxic Effect of Flavonol Myricetin in the Presence of Excess Copper. · 2021 · https://pubmed.ncbi.nlm.nih.gov/33562817/ · DOI 10.3390/molecules26040845
Complete structured claim and evidenceCopper sequestration opposed the known actions of metformin on AMPK-dependent signalling, and biguanide metal-binding was required for regulation of AMPK, glucose production, gluconeogenic gene expression, mitochondrial respiration and mitochondrial copper binding.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/metformin-research/22492524.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a0b1587d871d78b3bccefc5a47b277191faf6bc3b070dbe43295a0b21a633c56", "start_char": 0, "end_char": 1526, "text_sha256": "a0b1587d871d78b3bccefc5a47b277191faf6bc3b070dbe43295a0b21a633c56"}
- experimental_model
- Copper sequestration and biguanide analogues in cells, with mitochondrial measurements
- exposure
- Metformin and analogues with and without copper sequestration
- limitations
- A metal-dependence result using chemical sequestration and structural analogues. It does not establish that copper status in a person changes the drug’s effect.
- nutrient_topic
- Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. · Metformin
- organism
- Cultured cells
- plain_language
- Take copper away and the drug stops doing several of the things it normally does.
- primary_references
- [metformin-p22492524] Cellular responses to the metal-binding properties of metformin. (2012). https://pubmed.ncbi.nlm.nih.gov/22492524/ DOI: 10.2337/db11-0961
- tissue_or_cell_type
- Mitochondria and cytoplasm
Metformin: transport, molecular targets, gut mechanisms and nutrient interactions (2026-09-19) · lines 1347–1358
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Copper sequestration and biguanide analogues in cells, with mitochondrial measurements · source_derived_draft · unverified_draft
### metformin-copper-dependence-ampk Copper sequestration opposed the known actions of metformin on AMPK-dependent signalling, and biguanide metal-binding was required for regulation of AMPK, glucose production, gluconeogenic gene expression, mitochondrial respiration and mitochondrial copper binding. Condition category: normal nutrient_topic: Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. plain_language: Take copper away and the drug stops doing several of the things it normally does. organism: Cultured cells tissue_or_cell_type: Mitochondria and cytoplasm experimental_model: Copper sequestration and biguanide analogues in cells, with mitochondrial measurements limitations: A metal-dependence result using chemical sequestration and structural analogues. It does not establish that copper status in a person changes the drug’s effect. exposure: Metformin and analogues with and without copper sequestration evidence_span: {"source_cache": "artifacts/metformin-research/22492524.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a0b1587d871d78b3bccefc5a47b277191faf6bc3b070dbe43295a0b21a633c56", "start_char": 0, "end_char": 1526, "text_sha256": "a0b1587d871d78b3bccefc5a47b277191faf6bc3b070dbe43295a0b21a633c56"} [metformin-p22492524] Cellular responses to the metal-binding properties of metformin. (2012). https://pubmed.ncbi.nlm.nih.gov/22492524/ DOI: 10.2337/db11-0961
Complete structured claim and evidenceIn a gut simulator, many of the metformin-regulated genes in species from two different phyla encoded metalloproteins or metal transporters.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/metformin-research/28530702.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "885eedb24772fbd218ff6497da6c39f486d0e0b0293ddd97e8fd7b3f23330b11", "start_char": 0, "end_char": 1137, "text_sha256": "885eedb24772fbd218ff6497da6c39f486d0e0b0293ddd97e8fd7b3f23330b11"}
- experimental_model
- Four-month double-blind randomised trial with faecal transfer to germ-free mice and a gut simulator
- exposure
- Metformin or placebo for 4 months in treatment-naive type 2 diabetes
- limitations
- The faecal transfer carries the causal claim. The metalloprotein observation is a genomic annotation, not a measured metal interaction.
- nutrient_topic
- Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. · Metformin
- organism
- Human and mouse
- plain_language
- The genes the drug touched in bacteria were unusually often metal-handling genes.
- primary_references
- [metformin-p28530702] Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. (2017). https://pubmed.ncbi.nlm.nih.gov/28530702/ DOI: 10.1038/nm.4345
- tissue_or_cell_type
- Gut microbiome
Metformin: transport, molecular targets, gut mechanisms and nutrient interactions (2026-09-19) · lines 931–942
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Four-month double-blind randomised trial with faecal transfer to germ-free mice and a gut simulator · source_derived_draft · unverified_draft
### metformin-microbial-metalloproteins In a gut simulator, many of the metformin-regulated genes in species from two different phyla encoded metalloproteins or metal transporters. Condition category: normal nutrient_topic: Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. plain_language: The genes the drug touched in bacteria were unusually often metal-handling genes. organism: Human and mouse tissue_or_cell_type: Gut microbiome experimental_model: Four-month double-blind randomised trial with faecal transfer to germ-free mice and a gut simulator limitations: The faecal transfer carries the causal claim. The metalloprotein observation is a genomic annotation, not a measured metal interaction. exposure: Metformin or placebo for 4 months in treatment-naive type 2 diabetes evidence_span: {"source_cache": "artifacts/metformin-research/28530702.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "885eedb24772fbd218ff6497da6c39f486d0e0b0293ddd97e8fd7b3f23330b11", "start_char": 0, "end_char": 1137, "text_sha256": "885eedb24772fbd218ff6497da6c39f486d0e0b0293ddd97e8fd7b3f23330b11"} [metformin-p28530702] Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. (2017). https://pubmed.ncbi.nlm.nih.gov/28530702/ DOI: 10.1038/nm.4345
Complete structured claim and evidenceAt 10 mM, carnosine reduced DNA damage caused by copper- or iron/peroxide/ascorbate systems.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cell-free metal-catalyzed oxidation.
- limitations
- Millimolar assay; does not show safe systemic metal chelation.
- nutrient_topic
- Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
- plain_language
- Its chemical protection depended on the oxidation system.
- primary_references
- Antioxidant properties of carnosine re-evaluated with oxidizing systems involving iron and copper ions. · 2005 · https://pubmed.ncbi.nlm.nih.gov/15853927/ · DOI 10.1111/j.1742-7843.2005.pto_03.x
Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 308–314
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Cell-free metal-catalyzed oxidation. · source_derived_draft · unverified_draft
## carnosine-metal-dna Its chemical protection depended on the oxidation system. At 10 mM, carnosine reduced DNA damage caused by copper- or iron/peroxide/ascorbate systems. Model: Cell-free metal-catalyzed oxidation. Limitations: Millimolar assay; does not show safe systemic metal chelation. Evidence access: Primary abstract Antioxidant properties of carnosine re-evaluated with oxidizing systems involving iron and copper ions. · 2005 · https://pubmed.ncbi.nlm.nih.gov/15853927/ · DOI 10.1111/j.1742-7843.2005.pto_03.x
Complete structured claim and evidenceAdding carnosine lowered free HNE formation during copper-driven LDL oxidation.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cell-free LDL oxidation.
- limitations
- Cannot distinguish all contributions of trapping and oxidation suppression.
- nutrient_topic
- Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
- plain_language
- Aldehyde availability changed in an oxidizing lipid preparation.
- primary_references
- Dietary carnosine prevents early atherosclerotic lesion formation in apolipoprotein E-null mice. · 2013 · https://pubmed.ncbi.nlm.nih.gov/23559625/ · DOI 10.1161/ATVBAHA.112.300572
Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 324–330
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Cell-free LDL oxidation. · source_derived_draft · unverified_draft
## carnosine-oxidized-ldl Aldehyde availability changed in an oxidizing lipid preparation. Adding carnosine lowered free HNE formation during copper-driven LDL oxidation. Model: Cell-free LDL oxidation. Limitations: Cannot distinguish all contributions of trapping and oxidation suppression. Evidence access: Primary abstract Dietary carnosine prevents early atherosclerotic lesion formation in apolipoprotein E-null mice. · 2013 · https://pubmed.ncbi.nlm.nih.gov/23559625/ · DOI 10.1161/ATVBAHA.112.300572
Complete structured claim and evidenceOxidation of carnosine produced 2-oxo-carnosine; mechanistic analysis supported imidazole-radical formation followed by oxygen addition.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Chemical analysis, mouse tissues and human neuroblastoma cells.
- limitations
- Product formation is distinct from simple removal of oxidants.
- nutrient_topic
- Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
- plain_language
- An oxidation product can retain biological activity.
- primary_references
- 2-Oxo-histidine-containing dipeptides are functional oxidation products. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30504220/ · DOI 10.1074/jbc.RA118.006111
Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 340–346
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Chemical analysis, mouse tissues and human neuroblastoma cells. · source_derived_draft · unverified_draft
## carnosine-oxo-product An oxidation product can retain biological activity. Oxidation of carnosine produced 2-oxo-carnosine; mechanistic analysis supported imidazole-radical formation followed by oxygen addition. Model: Chemical analysis, mouse tissues and human neuroblastoma cells. Limitations: Product formation is distinct from simple removal of oxidants. Evidence access: Primary abstract 2-Oxo-histidine-containing dipeptides are functional oxidation products. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30504220/ · DOI 10.1074/jbc.RA118.006111
Complete structured claim and evidenceLysyl oxidase converts suitable peptidyl lysines to allysine, producing ammonia and hydrogen peroxide.
Experimental context and source evidence
- experimental_model
- LOXL2 assay development and total-family activity detection in cultured cells and tissue.
- limitations
- Substrate sites and enzyme-family members differ; peroxide production alone does not establish systemic oxidative injury.
- organism
- Mammalian cells/tissues and recombinant LOXL2; see study methods
- plain_language
- An enzyme creates reactive attachment sites used in matrix cross-linking.
- primary_references
- [lox-assay-2021] An in situ activity assay for lysyl oxidases (2021). https://pubmed.ncbi.nlm.nih.gov/34226627/
- tissue_or_cell_type
- Not specified as a whole tissue; see experimental model.
L-Lysine: mechanism-first literature curation (2026-09-17) · lines 467–475
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · LOXL2 assay development and total-family activity detection in cultured cells and tissue. · source_derived_draft · unverified_draft
### lox-peptidyl-lysine-oxidation Lysyl oxidase converts suitable peptidyl lysines to allysine, producing ammonia and hydrogen peroxide. Plain language: An enzyme creates reactive attachment sites used in matrix cross-linking. Condition category: normal organism: Mammalian cells/tissues and recombinant LOXL2; see study methods tissue_or_cell_type: Not specified as a whole tissue; see experimental model. experimental_model: LOXL2 assay development and total-family activity detection in cultured cells and tissue. limitations: Substrate sites and enzyme-family members differ; peroxide production alone does not establish systemic oxidative injury. [lox-assay-2021] An in situ activity assay for lysyl oxidases (2021). https://pubmed.ncbi.nlm.nih.gov/34226627/
Complete structured claim and evidenceLDL enriched with betanin showed a longer lag before copper-induced oxidation.
Experimental context and source evidence
- dose
- 25-100 micromolar pigment added to plasma; copper-triggered LDL oxidation
- duration
- Kinetic oxidation assay; incubation duration not specified in accessed abstract
- evidence_access
- Primary PubMed abstract; detailed exposure for PMID 23931157 additionally checked in publisher results. No uninspected full text is claimed.
- evidence_scope
- literature_reviewed; source-derived curation, not universally established human effects
- experimental_model
- Human pooled plasma from 10 healthy donors; isolated LDL
- limitations
- Plasma spiking exceeds typical dietary parent-pigment exposure; vitamin synergy refers only to this assay.
- nutrient_topic
- Betalains collection; each molecular form, species, exposure and preparation remains explicit. · Betalains
- organism
- Human pooled plasma from 10 healthy donors; isolated LDL
- plain_language
- LDL enriched with betanin showed a longer lag before copper-induced oxidation.
- primary_references
- Increased resistance to oxidation of betalain-enriched human low density lipoproteins. (2003). https://pubmed.ncbi.nlm.nih.gov/12868496/ DOI: 10.1080/1071576031000097490
- route
- Ex vivo spiking, not oral dosing
- tissue
- Plasma and LDL
Betalains: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 57–65
Original AI-assisted curation of twelve primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Human pooled plasma from 10 healthy donors; isolated LDL · source_derived_draft · unverified_draft
## betalains-betanin-ldl-oxidation LDL enriched with betanin showed a longer lag before copper-induced oxidation. Model/species: Human pooled plasma from 10 healthy donors; isolated LDL Tissue: Plasma and LDL Exposure: 25-100 micromolar pigment added to plasma; copper-triggered LDL oxidation Route: Ex vivo spiking, not oral dosing Duration: Kinetic oxidation assay; incubation duration not specified in accessed abstract Limits: Plasma spiking exceeds typical dietary parent-pigment exposure; vitamin synergy refers only to this assay. Primary reference: Increased resistance to oxidation of betalain-enriched human low density lipoproteins. (2003). https://pubmed.ncbi.nlm.nih.gov/12868496/ DOI: 10.1080/1071576031000097490
Complete structured claim and evidenceLDL enriched with indicaxanthin showed a longer lag before copper-induced oxidation.
Experimental context and source evidence
- dose
- 25-100 micromolar pigment added to plasma; copper-triggered LDL oxidation
- duration
- Kinetic oxidation assay; incubation duration not specified in accessed abstract
- evidence_access
- Primary PubMed abstract; detailed exposure for PMID 23931157 additionally checked in publisher results. No uninspected full text is claimed.
- evidence_scope
- literature_reviewed; source-derived curation, not universally established human effects
- experimental_model
- Human pooled plasma from 10 healthy donors; isolated LDL
- limitations
- Plasma spiking exceeds typical dietary parent-pigment exposure; vitamin synergy refers only to this assay.
- nutrient_topic
- Betalains collection; each molecular form, species, exposure and preparation remains explicit. · Betalains
- organism
- Human pooled plasma from 10 healthy donors; isolated LDL
- plain_language
- LDL enriched with indicaxanthin showed a longer lag before copper-induced oxidation.
- primary_references
- Increased resistance to oxidation of betalain-enriched human low density lipoproteins. (2003). https://pubmed.ncbi.nlm.nih.gov/12868496/ DOI: 10.1080/1071576031000097490
- route
- Ex vivo spiking, not oral dosing
- tissue
- Plasma and LDL
Betalains: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 77–85
Original AI-assisted curation of twelve primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Human pooled plasma from 10 healthy donors; isolated LDL · source_derived_draft · unverified_draft
## betalains-indicaxanthin-ldl-oxidation LDL enriched with indicaxanthin showed a longer lag before copper-induced oxidation. Model/species: Human pooled plasma from 10 healthy donors; isolated LDL Tissue: Plasma and LDL Exposure: 25-100 micromolar pigment added to plasma; copper-triggered LDL oxidation Route: Ex vivo spiking, not oral dosing Duration: Kinetic oxidation assay; incubation duration not specified in accessed abstract Limits: Plasma spiking exceeds typical dietary parent-pigment exposure; vitamin synergy refers only to this assay. Primary reference: Increased resistance to oxidation of betalain-enriched human low density lipoproteins. (2003). https://pubmed.ncbi.nlm.nih.gov/12868496/ DOI: 10.1080/1071576031000097490
Complete structured claim and evidenceBovine intermediate-pituitary granule amidation of D-Tyr-Val-Gly responded to ascorbate, with apparent substrate Km and Vmax changing as the ascorbate concentration changed.
Experimental context and source evidence
- cross_nutrient
- Vitamin C chemistry in collagen, modified-lysine/carnitine metabolism or copper-dependent peptide/catecholamine processing.
- experimental_model
- Bovine intermediate-pituitary secretory-granule kinetic assay
- exposure
- Synthetic D-Tyr-Val-Gly amidation with varied ascorbate, oxygen and divalent-metal chelators/copper.
- limitations
- The old granule preparation is not a purified modern PAM-domain assay; synthetic substrate kinetics do not quantify all hormone amidation.
- nutrient_topic
- Vitamin C research collection; topical membership is not evidence of a direct dietary effect. · Vitamin C
- organism
- Bos taurus
- plain_language
- Vitamin C helps the pituitary enzyme finish a peptide with an amide group.
- primary_references
- [pam1983] Identification in pituitary tissue of a peptide alpha-amidation activity that acts on glycine-extended peptides and requires molecular oxygen, copper, and ascorbic acid. (1983). https://pubmed.ncbi.nlm.nih.gov/6576381/ DOI: 10.1073/pnas.80.16.5144
- tissue_or_cell_type
- Pituitary secretory granules
Vitamin C: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 859–870
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Bovine intermediate-pituitary secretory-granule kinetic assay · source_derived_draft · unverified_draft
### vc-enzyme-bovine-amidation-ascorbate Bovine intermediate-pituitary granule amidation of D-Tyr-Val-Gly responded to ascorbate, with apparent substrate Km and Vmax changing as the ascorbate concentration changed. Condition category: normal nutrient_topic: Vitamin C research collection; topical membership is not evidence of a direct dietary effect. plain_language: Vitamin C helps the pituitary enzyme finish a peptide with an amide group. organism: Bos taurus tissue_or_cell_type: Pituitary secretory granules experimental_model: Bovine intermediate-pituitary secretory-granule kinetic assay limitations: The old granule preparation is not a purified modern PAM-domain assay; synthetic substrate kinetics do not quantify all hormone amidation. cross_nutrient: Vitamin C chemistry in collagen, modified-lysine/carnitine metabolism or copper-dependent peptide/catecholamine processing. exposure: Synthetic D-Tyr-Val-Gly amidation with varied ascorbate, oxygen and divalent-metal chelators/copper. [pam1983] Identification in pituitary tissue of a peptide alpha-amidation activity that acts on glycine-extended peptides and requires molecular oxygen, copper, and ascorbic acid. (1983). https://pubmed.ncbi.nlm.nih.gov/6576381/ DOI: 10.1073/pnas.80.16.5144
Complete structured claim and evidenceAscorbate reduced enzyme-bound copper in purified bovine dopamine beta-hydroxylase from Cu(II) to Cu(I), as examined by X-ray absorption spectroscopy.
Experimental context and source evidence
- cross_nutrient
- Vitamin C chemistry in collagen, modified-lysine/carnitine metabolism or copper-dependent peptide/catecholamine processing.
- experimental_model
- Bovine dopamine beta-hydroxylase X-ray absorption and EXAFS
- exposure
- Ascorbate reduction of purified Cu(II)-DBH to Cu(I)-DBH.
- limitations
- Purified bovine enzyme, not a dietary copper-status measurement. Scott 1988 and Blumberg 1989 disagree on the detailed coordination change and heavy-atom ligation; this record retains only the shared Cu(II)-to-Cu(I) redox conclusion.
- nutrient_topic
- Vitamin C research collection; topical membership is not evidence of a direct dietary effect. · Vitamin C
- organism
- Bos taurus
- plain_language
- Vitamin C supplies reducing power to copper held inside this neurotransmitter enzyme.
- primary_references
- [scott1988] The copper sites of dopamine beta-hydroxylase: an X-ray absorption spectroscopic study. (1988). https://pubmed.ncbi.nlm.nih.gov/3179263/ DOI: 10.1021/bi00415a005 [blumberg1989] X-ray absorption spectroscopic study of the active copper sites in dopamine beta-hydroxylase. (1989). https://pubmed.ncbi.nlm.nih.gov/2703478/ DOI: 10.1016/s0021-9258(18)83307-5
- tissue_or_cell_type
- Adrenal-medullary enzyme preparation
Vitamin C: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 793–805
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Bovine dopamine beta-hydroxylase X-ray absorption and EXAFS · source_derived_draft · unverified_draft
### vc-enzyme-dbh-copper-reduction Ascorbate reduced enzyme-bound copper in purified bovine dopamine beta-hydroxylase from Cu(II) to Cu(I), as examined by X-ray absorption spectroscopy. Condition category: normal nutrient_topic: Vitamin C research collection; topical membership is not evidence of a direct dietary effect. plain_language: Vitamin C supplies reducing power to copper held inside this neurotransmitter enzyme. organism: Bos taurus tissue_or_cell_type: Adrenal-medullary enzyme preparation experimental_model: Bovine dopamine beta-hydroxylase X-ray absorption and EXAFS limitations: Purified bovine enzyme, not a dietary copper-status measurement. Scott 1988 and Blumberg 1989 disagree on the detailed coordination change and heavy-atom ligation; this record retains only the shared Cu(II)-to-Cu(I) redox conclusion. cross_nutrient: Vitamin C chemistry in collagen, modified-lysine/carnitine metabolism or copper-dependent peptide/catecholamine processing. exposure: Ascorbate reduction of purified Cu(II)-DBH to Cu(I)-DBH. [scott1988] The copper sites of dopamine beta-hydroxylase: an X-ray absorption spectroscopic study. (1988). https://pubmed.ncbi.nlm.nih.gov/3179263/ DOI: 10.1021/bi00415a005 [blumberg1989] X-ray absorption spectroscopic study of the active copper sites in dopamine beta-hydroxylase. (1989). https://pubmed.ncbi.nlm.nih.gov/2703478/ DOI: 10.1016/s0021-9258(18)83307-5
Complete structured claim and evidenceExpression of the bovine PHM-only construct in HEK293 cells increased secreted PHM activity, demonstrating a functional hydroxylating domain separable from the PAL portion of PAM.
Experimental context and source evidence
- cross_nutrient
- Vitamin C chemistry in collagen, modified-lysine/carnitine metabolism or copper-dependent peptide/catecholamine processing.
- experimental_model
- Purified bovine pituitary PAL and bovine-domain expression constructs in HEK293 cells
- exposure
- Purified PAL with N-acetyl-Tyr-Val-alpha-hydroxyglycine; PHM or PAL-containing constructs expressed in HEK293.
- limitations
- Bovine protein expressed in human cells is not a human PAM protein; domain construct activity does not quantify tissue hormone synthesis.
- nutrient_topic
- Vitamin C research collection; topical membership is not evidence of a direct dietary effect. · Vitamin C
- organism
- Bos taurus (protein); Homo sapiens (expression host)
- plain_language
- Peptide amidation begins with a separate vitamin-C-dependent hydroxylation step.
- primary_references
- [pal1991] Peptidyl-alpha-hydroxyglycine alpha-amidating lyase. Purification, characterization, and expression. (1991). https://pubmed.ncbi.nlm.nih.gov/1902227/ DOI: 10.1016/s0021-9258(20)89524-6
- tissue_or_cell_type
- Bovine neurointermediate pituitary; heterologous HEK293
Vitamin C: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 885–896
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified bovine pituitary PAL and bovine-domain expression constructs in HEK293 cells · source_derived_draft · unverified_draft
### vc-enzyme-pam-two-domains Expression of the bovine PHM-only construct in HEK293 cells increased secreted PHM activity, demonstrating a functional hydroxylating domain separable from the PAL portion of PAM. Condition category: normal nutrient_topic: Vitamin C research collection; topical membership is not evidence of a direct dietary effect. plain_language: Peptide amidation begins with a separate vitamin-C-dependent hydroxylation step. organism: Bos taurus (protein); Homo sapiens (expression host) tissue_or_cell_type: Bovine neurointermediate pituitary; heterologous HEK293 experimental_model: Purified bovine pituitary PAL and bovine-domain expression constructs in HEK293 cells limitations: Bovine protein expressed in human cells is not a human PAM protein; domain construct activity does not quantify tissue hormone synthesis. cross_nutrient: Vitamin C chemistry in collagen, modified-lysine/carnitine metabolism or copper-dependent peptide/catecholamine processing. exposure: Purified PAL with N-acetyl-Tyr-Val-alpha-hydroxyglycine; PHM or PAL-containing constructs expressed in HEK293. [pal1991] Peptidyl-alpha-hydroxyglycine alpha-amidating lyase. Purification, characterization, and expression. (1991). https://pubmed.ncbi.nlm.nih.gov/1902227/ DOI: 10.1016/s0021-9258(20)89524-6
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.